Applications of quantile regression to estimation and detection of some tail characteristics by Hsu, Ya-Hui
c© 2010 Ya-Hui Hsu
APPLICATIONS OF QUANTILE REGRESSION TO ESTIMATION AND
DETECTION OF SOME TAIL CHARACTERISTICS
BY
YA-HUI HSU
DISSERTATION
Submitted in partial fulfillment of the requirements
for the degree of Doctor of Philosophy in Statistics
in the Graduate College of the
University of Illinois at Urbana-Champaign, 2010
Urbana, Illinois
Doctoral Committee:
Professor Xuming He, Chair
Professor Roger Koenker
Assistant Professor Feng Liang
Professor Steve Portnoy
Abstract
The statistical inference based on the ordinary least squares regression is sub-optimal when the
distributions are skewed or when the quantity of interest is the upper or lower tail of the distributions.
For example, the changes in Total Sharp Scores (TSS), the primary measurements of the treatment
effects on prevention of structural damage for rheumatoid arthritis, are nearly identical for most
therapies for nearly 75% of the patient population, but the difference lies in the most challenging
25% of the patient population where a less effective treatment loses its efficacy, resulting in a heavy
right tail in its distribution.
In the first part of the dissertation, we develop the Expected Shortfall (ES), the Covariate-
adjusted Expected Shortfall (COVES), and the Generalized Covariate-adjusted Expected Shortfall
(q.COVES) tests under the framework of quantile regression. Those tests focus specifically on one
tail of the outcome distributions. The ES test applies to two-sample comparisons. The COVES test
adjusts for covariates, and is shown to be valid for i.i.d (independent and identically distributed)
error models or when the covariates have the same means across treatments. The q.COVES test
generalizes the COVES test to more general models. We show the proposed tests can achieve a
substantial sample size reduction over the conventional tests on mean effects.
The second part of the dissertation focuses on a popular measure of risk used by financial
institutions, Value at Risk (VaR), defined as a quantile of the loss distribution of a portfolio within
a given time period and a confidence level. Accurate VaR estimation can help financial institutions
maintain appropriate capital levels to cover the risk from the corresponding portfolio. We use an
MCMC strategy along with a block algorithm to perform Bayesian inference on the Conditional
Autoregressive Value at Risk (CAViaR) models proposed by Engle and Manganelli (2004) based on
quantile regression. Using the S&P 500 index as an example, we show that the proposed Bayesian
approach adds value to the original estimation method of Engle and Manganelli in terms of both
estimation and prediction.
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Chapter 1
Expected Shortfall Test for
Detection of Treatment Effects
1.1 Introduction
We consider the problem of testing the hypothesis of no treatment effect against a class of alternatives
where the two outcome distributions differ only or mainly in the right tail. As demonstrated in
some recent trials of rheumatoid arthritis therapies in van der Heijde et al. (2006) and Kremer et al.
(2006), the changes in Total Sharp Scores (TSS), the primary measurements of the treatment effects
on prevention of structural damage, are nearly identical for most therapies for nearly 75% of the
patient population, but the difference lies in the most challenging 25% of the patient population
where a less effective treatment loses its efficacy, resulting in a heavy right tail in its distribution.
The two-sample t test or its regression counterpart in covariate-adjusted linear models is commonly
used for detecting the treatment effects, but due to skewness and heavy-tails of the distributions, the
test does not have satisfactory power. Nonparametric tests on the median differences, for example,
would fare even worse in such cases, because the median differences are often negligible among
those therapies. Some trials have considered the chi-square tests on the proportion of patients with
little disease progression by dichotomizing TSS, but there has been no agreeable cutoff point for
dichotomization. In fact, the power of the chi-square test depends rather critically on the cutoff
point. In addition, it is difficult to perform the chi-square test when a covariate needs to be adjusted
for.
We believe that a most natural test in this type of applications is to focus on the average in one
tail, or the expected tail loss (aka expected shortfall, abbreviated as ES). In finance, this is also called
the conditional value at risk (C-VaR) (Artzner et al., 1999), for measuring the risk of a portfolio.
We average the changes in TSS in the upper tail. A treatment is said to be more effective if it has
a smaller expected shortfall, where the expected shortfall is defined to be the conditional mean of
the outcome (e.g., change in TSS) above the τ -th quantile. In this paper, τ will be taken to be a
user specified value (e.g., 0.75), but a good choice of τ clearly depends on the area of applications.
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In finance, the most relevant choices of τ fall above 0.90.
O’Brien (1998) proposes the generalized t-test and the generalized rank sum test to incorporate
heterogeneous treatment effects. These tests have good power against location-scale changes, but
are limited to two-sample comparisons without covariates. A main advantage of the ES test is that
it generalizes to adjust for covariates, and the generalization will appear in the next chapter.
The remainder of this chapter is organized as follows. We start with a brief introduction to our
motivating example on the TSS for rheumatoid arthritis therapies in the next section. Next, we
propose the ES test based on the expected shortfalls and compare the proposed ES test with the t
test and the χ2 test in empirical power.
1.2 A Premier on Total Sharpe Scores
Rheumatoid arthritis (RA) is a chronic disabling disease that causes destruction of joint cartilage
and erosion of adjacent bones. In RA clinical trials, TSS is used to measure the treatment effect of
RA drugs on prevention of structural damage to the joints. It consists of two components, erosion
score and score for joint space narrowing (JSN), which are obtained through examination of hand
and/or feet joints with radiographic methods. The first description of TSS is given by Sharp et al.
(1971), but TSS has been modified in later studies. The example presented in this section is based
on van der Heijde’s modification of TSS scoring system (van der Heijde, 2000), which is based on
examination of 16 areas for erosions and 15 for joint space narrowing in each hand. The erosion
score per joint ranges from 0 to 5 with 0 representing a normal condition and 5 the most severe
disease, and thus the total erosion score ranges from 0 to 160 (16 areas by 2 hands by 5). The JSN
score ranges from 0 to 4 per joint with higher score representing more severe disease, which leads to
a range of 0 to 120 (15 areas by 2 hands by 4) for the total JSN score. Therefore, the range of TSS
is 0 to 280. The primary interest is the change from baseline in TSS in one or two years.
The change in TSS has a highly skewed distribution under any known treatment. In the TEMPO
trial (van der Heijde et al., 2006) comparing Methotrexate, Etanercept, and the combination therapy
of Etanercept and Methotrexate, the three treatments are similarly effective for about 75% of the
patients whose conditions improved or showed no or little progression from the baseline; see Figure
1.1. Medians for all three groups are around 0. Treatment differences come from the 25% of the
patients with the most progressive diseases. In other words, the differences in treatment effects are
not attributed to a location-scale change in the distributions. The distributions of clinical data from
2
several other major RA trials (Kremer et al., 2006; Keystone et al., 2004; Lipsky et al., 2000) showed
similar characteristics.
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Figure 1.1: This figure, reproduced from van der Heijde et al. (2006), shows that the changes in
TSS from the TEMPO trials differ mostly in the upper tails.
Later in this chapter, we use a recent observational study conducted at Brigham and Women’s
Hospital and sponsored by Millennium Pharmaceuticals Inc. and Biogen Idec as a basis for assessing
the performance of the proposed test. We take 150 subjects in the study, who are under active
treatment, and simulate a control group whose outcome distribution is chosen to mimic the treatment
difference reported in other trials. For example, in the Adalimumab trial (Keystone et al., 2004),
the variance of the treatment group (using the drug Adalimumab 20mg/kg) is about half of that in
the control group (using the drug Methotrexate) with a mean difference of -1.9. In the Abatacept
trial (Kremer et al., 2006), the variance in the Abatacept group is about one third of that in the
control group. In our simulation studies, we use the ratio of variances between 2:1 and 3:1 between
two treatment groups.
1.3 Expected Shortfall (ES)
We use a dummy variable D as treatment indicator, and Z as the outcome measure. For simplicity
of notation, we consider D taking values 0 or 1, but the work generalizes readily for multiple
treatments. Expected shortfall (ES), also called Conditional Value at Risk (C-VaR) (Artzner et al.,
1999) or Conditional Tail Expectation (CTE) or Tail-VaR, is the expected loss given that the loss
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has already exceeded the τth quantile of the loss distribution for some τ ∈ (0, 1). Expected
shortfall is a robust and coherent measure (Artzner et al., 1999) for risk exposure expressed as
ESτ (F ) = 11−τ
∫ 1
τ
F−1(u)du for all loss distribution function, F .
Let Z be the outcome measure for the treatment (d = 1) and control (d = 0) groups with
distributions F1 and F0, respectively. The hypothesis corresponding to expected shortfalls is stated
as
H0 : ESτ (F0) = ESτ (F1) versus H1 : ESτ (F0) = ESτ (F1) + δ, for some δ 6= 0,
where ESτ (F1) and ESτ (F0) are the expected shortfalls for the treatment group and the control
group, respectively, and δ is the effect size.
Given a random sample Z for group d, the empirical expected shortfall is
ESτ (d) =
∑
Di=d
wd,iZ(i),
where Z(i) is the ith order statistic of Z for group d, nd =
∑
i I(Di = d), wd,i = (nd− [ndτ ])−1I(i >
[ndτ ]) are the weights for group d, with [x] denoting the largest integer not to exceed x, and I
denoting the indicator function. The quantity ESτ (d) is the average of the outcomes for group d
that are above the τ -th quantile. The proposed ES test statistic is given as
TESτ (n1, n0) = ESτ (1)− ESτ (0). (1.1)
The ES test statistic in (1.1) is a linear function of order statistics, which is recognized as an
L-estimator (Lehmann, 1983). Stigler (1974) shows that the L-estimator is asymptotically nor-
mal under some conditions. By using Theorem 5.1 of Lehmann (1983, p.369), we can obtain the
asymptotic mean and variance of TESτ (n1, n0).
Theorem 1.3.1. (Theorem 5.1 of Lehmann, 1983)
Let X1, ..., Xn be iid over an interval (a, b),−∞ ≤ a < b ≤ ∞ according to a distribution F for
which E(X2i ) <∞ and which possesses a density f with 0 < f(x) for all a < x < b
(i) Let Ln = 1n
n∑
i=1
λ( in+1 )X(i) where λ is a bounded function defined over (0, 1) which is continuous
a.e. (with respect to Lebesgue measure) and satisfies
∫ 1
0
λ(t)dt = 1. Let µ(F, λ) =
∫ 1
0
λ(u)F−1(u)du
and σ2(F, λ) =
∫ 1
0
A2(t)dt− (∫ 1
0
A(t)dt)2 where A is any function with derivative A′(t) = λ(t)f [F−1(t)] .
Then the distribution of
√
n(Ln−µ(F, λ))/σ(F, λ) tends to the standard normal distribution N(0, 1)
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as n→∞, provided σ2(F, λ) > 0.
(ii) The result of part (i) remains valid if the density λ is replaced by λn, provided the sequence λn
is uniformly bounded and λn(t) → λ(t) where λ is continuous a.e. and the convergence is uniform
in a neighborhood of any continuity point of λ.
We quote the result from Theorem 1.3.1, and apply this to establish the asymptotic normality
of the test statistic for (1.1) as n1, n0 →∞.
Theorem 1.3.2. Let (Zi, Di) with Di = 1 for i = 1, · · · , n1 and Di = 0 for i = n1+1, · · · , n1+n0,
Z be a combination of two random samples according to distributions F1 and F0, respectively, with
finite second moments, then
(TESτ (n1, n0)− µES)/σESn1,n0
D→ N(0, 1), as n1, n0 →∞
with asymptotic mean
µES = ESτ (F1)− ESτ (F0),
and asymptotic variance
(σESn1,n0)
2 = σ2(F1, τ)/n1 + σ2(F0, τ)/n0,
where
ESτ (Fd) =
1
1− τ
∫ 1
τ
F−1d (u)du,
σ2(Fd, τ) =
1
(1− τ)2
∫ 1
τ
(F−1d (t)− F−1d (τ))2dt−
( 1
1− τ
∫ 1
τ
(F−1d (t)− F−1d (τ))dt
)2
, d = 0, 1.
Proof of Theorem 1.3.2 Let λ(t) = 11−τ I(τ < t < 1), where λ(t) is bounded and continuous a.e.
over (0, 1) and satisfies
∫ 1
0
λ(t)dt = 1. According to Theorem 1.3.1, ESτ (d) is asymptotically normal
with mean µd = 11−τ
∫ 1
τ
F−1d (u)du and variance σ
2
d = σ
2(Fd, τ)/nd, where d = 0, 1.
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To compute σ2(Fd, τ), we follows Theorem 1.3.1 to get A′Zd(t), and AZd(t) first.
A′Zd(t) =
1
1− τ
1
fd(F−1d (u))
I(τ < t < 1),
AZd(t) =
∫ t
τ
1
1− τ
1
fd(F−1d (u))
du =
1
1− τ (F
−1
d (t)− F−1d (τ))I(τ < t < 1),
σ2(Fd, τ) =
∫ 1
0
A2Zd(t)dt− (
∫ 1
0
AZd(t)dt)
2
=
1
(1− τ)2
∫ 1
τ
(F−1d (t)− F−1d (τ))2dt−
( 1
1− τ
∫ 1
τ
(F−1d (t)− F−1d (τ))dt
)2
.
Since Z are independent for d = 0 and d = 1, TESτ (n1, n0) is asymptotically normal with the mean
and the variance specified in this theorem. 
Lemma 1.3.1. Let Z be a combination of two random samples according to distributions F1 and
F0, respectively, with finite second moments. We have
Z([ndτ ]) = F
−1
d (τ) + op(1),
(Z([ndτ ]))
2 = (F−1d (τ))
2 + op(1),
1
(1− τ)nd
∑
i>[ndτ ], Di=d
Z(i) =
1
1− τ
∫ 1
τ
F−1d (t)dt+ op(1),
1
(1− τ)nd
∑
i>[ndτ ], Di=d
(Z(i))2 =
1
1− τ
∫ 1
τ
(F−1d (t))
2dt+ op(1).
Proof of Lemma 1.3.1 According to Serfling (2002),
√
nd(Z([ndτ ]) − F−1d (τ))
D→ N(0, τ(1− τ){fd(F−1d (τ))}2
), as nd →∞,
Z([ndτ ]) = F
−1
d (τ) +Op(n
−1/2
d ) = F
−1
d (τ) + op(1), and (Z([ndτ ]))
2 = (F−1d (τ))
2 + op(1).
Besides,
1
(1− τ)nd
∑
i>[ndτ ], Di=d
Z(i) =
1
1− τ [
1
nd
∑
Di=d
{ZiI(Zi ≥ F−1d (τ))}] + op(1)
=
1
1− τ E
(
ZiI(Zi ≥ F−1d (τ), Di = d)
)
+ op(1)
=
1
1− τ
∫ ∞
F−1d (τ)
zdFd(z) + op(1)
=
1
1− τ
∫ 1
τ
F−1d (t)dt+ op(1).
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Similarly, we can prove
1
(1− τ)nd
∑
i>[ndτ ], Di=d
(Z(i))2 =
1
1− τ
∫ 1
τ
(F−1d (t))
2dt+ op(1). 
Theorem 1.3.3. Let Z be a combination of two random samples according to distributions F1 and
F0, respectively, with finite second moments. Under the null hypothesis that µES = 0, we have
TESτ (n1, n0)/s
ES
n1,n0
D→ N(0, 1), as n1, n0 →∞,
where
(sESn1,n0)
2 = V ES1 /n1 + V
ES
0 /n0,
and
V ESd = (1− τ)−2n−1d
∑
i>[ndτ ], Di=d
{Z(i) − Z([ndτ ])}2 −
[{(1− τ)nd}−1 ∑
i>[ndτ ], Di=d
{Z(i) − Z([ndτ ])}
]2
is the consistent estimator for σ2(Fd, τ).
Proof of Theorem 1.3.3 According to Lemma 1.3.1,
1
(1− τ)nd
∑
i>[ndτ ], Di=d
{Z(i) − Z([ndτ ])} and
1
(1− τ)nd
∑
i>[ndτ ], Di=d
{Z(i) − Z([ndτ ])}2
are consistent estimators for
1
1− τ
∫ 1
τ
(F−1d (t)− F−1d (τ))dt and
1
1− τ
∫ 1
τ
(F−1d (t)− F−1d (τ))2dt, respectively.
Finally, according to Theorem 1.3.2, the proof is complete. 
1.4 Simulations
Suppose that Z is the response variable under two treatments according to distributions F1 and F0.
We consider the problem of testing the null hypothesis that ESτ (F0) =ESτ (F1) versus two-sided
alternative hypothesis. Four tests are considered to detect the treatment effect, where the difference
may lie in the upper tail of the distributions. The 0.5th/0.75th ES test is based on the difference
in the expected loss above the 0.5th/0.75th quantile, the χ2 test is based on a 2 by 2 table, where
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success is defined as the measurement below a given cutoff point, and the t test is based on the
difference in the sample means. Since the cutoff point is critical in determining the power, we choose
it to be median over one standard deviation of the treatment group as van der Heijde et al. (2006)
suggested.
As in the Adalimumab and Abatacept trials (Keystone et al., 2004; Kremer et al., 2006), in
which the variance of the treatment group is around half or one third of that of the control group,
the treatment group usually has a smaller variance, and a similar or larger sample size than the
control group does. So in the simulation study, we take the ratio of sample size (n1/n0) to be 1 or
2, where n1 and n0 are the sample sizes for the treatment and control group, respectively. In this
section, we report some power studies of the proposed test based on Monte Carlo simulations.
1.4.1 Some Simulation Studies
We consider data generated from three studies in the analysis.
• Study 1, normal models: Zi = 5 + {1 + ηI(ei > 0)I(Di = 0)}ei, where ei ∼ N(0, 1), and η is
either 0 (under the null hypothesis) or 1.35 (under the alternative hypothesis).
• Study 2, Chi-square models with agreement up to the median: Zi = ei + η(ei − med)I(ei >
med)I(Di = 0), where ei ∼ χ2(ν), degree of freedom (ν) = 2, median (med) ≈ 1.4, and η is
either 0 (under the null hypothesis) or 0.85 (under the alternative hypothesis).
• Study 3, Chi-square models with agreement up to a higher quantile: Zi = ei+η(ei−2.2)I(ei >
2.2)I(Di = 0), where ei ∼ χ2(ν), degree of freedom (ν) = 2, and η is either 0 (under the null
hypothesis) or 1.05 (under the alternative hypothesis).
Clearly, the control group (d = 0) has a heavier right tail. Figure 1.2 shows the density function
for two groups in each study. When η equals to the value under the alternative hypothesis, the error
variance of the control group (d = 0) is about triple that of the treatment group (d = 1) in each
study. Table 1.1 summarizes the differences of the two groups under the alternative hypothesis in
each study.
Type I Error and Histogram of p-values
A total of M = 10, 000 Monte Carlo samples of size n1 = n0 = 50 are generated for Z under the
null hypothesis (with η = 0). We show the histograms of the p-values computed from all tests for
three studies in Figure 1.3 and Figure 1.4. The Type I errors stay around the nominal level 5%, but
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Figure 1.2: Density functions of the treatment outcomes for the control group and treatment group,
respectively. The upper tail of the control group is heavier than the treatment group. (a) Study 1.
(b) Study 2. (c) Study 3.
the p-values from the χ2 test deviates a little from the uniform distribution, which means the χ2
approximation is not very accurate. The standard error of the Type I error estimate given under
each figure is around 0.2% except for the χ2 test.
Power Function
We compare power functions for these four tests, and then provide the sample sizes needed for each
test to reach power 0.9. A total of M = 10, 000 Monte Carlo samples are generated for Z under the
alternative hypothesis (with η = 1.35, 0.85, and 1.05, respectively for Studies 1-3). The grid is 10
for sample size, and we use smoothing splines to obtain power curves. The cutoff point in the χ2
test is 6 for Study 1, and 3.4 for Studies 2 and 3. Figure 1.5 shows that the 0.5th/0.75th ES test
is more powerful than the χ2 test and the t test. Under the alternative hypothesis, the ES test is
indeed better for detecting a difference than the χ2 and the t tests. The results from Figure 1.5 and
9
Table 1.1: Difference of the two groups (d = 0 vs d = 1) under the alternative hypothesis in each
study, with the last column for the ratio of error variances.
τ 0.5 0.6 0.7 0.75 0.8 0.9 mean var ratio
Study 1 (η = 1.35) 0 0.34 0.70 0.91 1.13 1.72 0.54 2.97
Study 2 (η = 0.85) 0 0.37 0.85 1.16 1.54 2.73 0.84 2.96
Study 3 (η = 1.05) 0 0 0.22 0.60 1.07 2.52 0.70 3.07
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Figure 1.3: Histograms of p-values for Study 1. (a) 0.5th ES test, Type I error = 0.0502. (b) 0.75th
ES test, Type I error = 0.0512. (c) χ2 test, Type I error = 0.0522. (d) t test, Type I error = 0.0496.
Table 1.2 clearly show the superiority of the ES test. In Study 1, if we use the t test, we need to
have a sample size twice as large compared to the ES test.
10
Histogram of pvalue
pvalue
Fr
eq
ue
nc
y
0.0 0.2 0.4 0.6 0.8 1.0
0
20
0
60
0
10
00
(a)
Histogram of pvalue
pvalue
Fr
eq
ue
nc
y
0.0 0.2 0.4 0.6 0.8 1.0
0
40
0
80
0
12
00
(c)
Histogram of pvalue
pvalue
Fr
eq
ue
nc
y
0.0 0.2 0.4 0.6 0.8 1.0
0
20
0
60
0
10
00
(b)
Histogram of pvalue
pvalue
Fr
eq
ue
nc
y
0.0 0.2 0.4 0.6 0.8 1.0
0
20
0
60
0
10
00
(d)
Figure 1.4: Histograms of p-values for Study 2 and Study 3. (a) 0.5th ES test, Type I error = 0.0498.
(b) 0.75th ES test, Type I error = 0.0483. (c) χ2 test, Type I error = 0.0512. (d) t test, Type I
error = 0.0499.
Table 1.2: Comparisons of four tests. (a) Type I error at sample size (n1, n0) = (50, 50). The
values in the table are in percentage. (b) Sample size (n1, n0) needed to reach power 0.9 under the
alternative hypothesis. In each study, the first row uses n1 = n0, and the second row uses n1 = 2n0.
0.5th ES test 0.75th ES test χ2 test t test
Study (a) (b) (a) (b) (a) (b) (a) (b)
1 5.02 (76, 76) 5.12 (50, 50) 5.22 (121, 121) 4.96 (141, 141)
(136, 68) (92, 46) (180, 90) (242, 121)
2 4.98 (180, 180) 4.83 (147, 147) 5.12 (331, 331) 4.99 (221, 221)
(308, 154) (260, 130) (490, 245) (372, 186)
3 4.98 (274, 274) 4.83 (195, 195) 5.12 (817, 817) 4.99 (335, 335)
(490, 245) (342, 171) (1214, 607) (560, 280)
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Figure 1.5: Statistical powers of four tests as functions of sample size n1 = n0 = n. (a) Study 1.
(b) Study 2. (c) Study 3.
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1.4.2 Targeted Study on TSS
Two scenarios (with variance ratio 2 and 3, respectively) are constructed based on the data we
obtained from a recent study on an undisclosed therapy to treat RA at the Brigham and Women’s
Hospital in Boston. Since the cutoff point is critical to determining the power, we choose the cutoff
point to be one standard deviation of the treatment group as van der Heijde et al. (2006) suggested.
One standard deviation is around 5.84 for this study. When the group differences occur at one tail
of the distributions, we find that the proposed ES test greatly outperforms the t test.
TSS Data with Agreement up to certain Quantiles
We use the empirical distributions of the TSS changes of 150 patients in the Brigham and Women’s
Hospital study as the underlying distribution for the group d = 1. If this distribution is denoted as
F (taken to be the empirical distribution from the data), the outcome measurement for the control
group (with d = 0) will be simulated according to the following two scenarios.
• Scenario 1, agreement up to 0.65th quantile: Z = F−1(u) + 8|u− 0.65|1/4I(u > 0.65),
• Scenario 2, agreement up to 0.75th quantile: Zi = F−1(u) + 61|u− 0.75|I(u > 0.75),
where u is a uniform random number in (0, 1). Clearly, the control group (d = 0) has a heavier right
tail. In fact, the variance of the control group (d = 0) is about twice and triple that of the treatment
group (d = 1) under theses two scenarios, respectively. Figure 1.6 and Table 1.3 summarize the
differences of the two groups.
0 20 40 60 80 100
−
20
0
10
20
30
Cumulative Probability
C
ha
ng
e 
fro
m
 B
as
el
in
e
Control
Treatment
(a)
0 20 40 60 80 100
−
10
0
10
20
30
40
Cumulative Probability
C
ha
ng
e 
fro
m
 B
as
el
in
e
Control
Treatment
(b)
Figure 1.6: Cumulative probability distribution of the TSS change shows that the groups differ
mostly in the upper trials. (a) Scenario 1. (b) Scenario 2.
Type I Error and Histogram of p-values
Histograms of the p-values at a total of M = 10, 000 Monte Carlo samples of size n1 = n0 = 100
from these tests for these two scenarios are shown in Figure 1.7. From Figure 1.7, we find that the
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Table 1.3: Differences in the τ -th quantiles and in the mean, with the last column as the ratio of
the variances between the control group (d = 0) and the treatment group (d = 1):
τ 0.5 0.6 0.7 0.75 0.8 0.9 0.99 mean var ratio
Scenario 1 0 0 3.72 4.53 4.96 5.64 6.02 1.74 2.03
Scenario 2 0 0 0.03 1.14 3.24 9.08 14.58 1.99 3.02
results are similar to Section 1.4.1.
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Figure 1.7: Histograms of p-values for both scenarios (a) 0.5th ES test, Type I error = 0.0500. (b)
0.75th ES test, Type I error = 0.0502. (c) χ2 test, Type I error = 0.0491. (d) t test, Type I error
= 0.0501.
Power Function
A total of M = 10, 000 Monte Carlo samples are generated for Z. The power functions for all tests
in each scenario are shown in Figure 1.8 with sample sizes up to n1 = n0 = 350. The grid is 10
for sample size, and we use smoothing splines to obtain power curves. Table 1.4 reports the Type I
errors at the sample size of n1 = n0 = 100. It also reports the sample sizes needed to reach power of
0.90 in each scenario under two design conditions: n1 = n0 and n1 = 2n0, respectively. The results
clearly show that both the ES test and the χ2 test outperform the t test in these two scenarios.
Besides, the ES test outperforms the χ2 test in Scenario 2 but not in Scenario 1.
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Figure 1.8: Statistical powers of four tests in reference with the TSS data with agreement up to the
(a) 0.65th quantile and (b) 0.75th quantile, as functions of sample size n1 = n0 = n.
Table 1.4: Comparisons of four tests. (a) Type I error at sample size (n1, n0) = (100, 100). The
values in the table are in percentage. (b) Sample size (n1, n0) needed to reach power 0.9 under the
alternative hypothesis. In each study, the first row uses n1 = n0, and the second row uses n1 = 2n0.
0.5th ES tets 0.75th ES test χ2 test t test
Scenario (a) (b) (a) (b) (a) (b) (a) (b)
1 5.00 (170, 170) 5.02 (110, 110) 4.91 (85, 85) 5.01 (310, 310)
(276, 138) (158, 79) (124, 62) (508, 254)
2 5.00 (188, 188) 5.02 (130, 130) 4.91 (270, 270) 5.01 (310, 310)
(322, 161) (230, 115) (390, 195) (520, 260)
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Chapter 2
Covariate-adjusted Expected
Shortfall Test
2.1 Test Based on Covariate-adjusted Expected Shortfall
(COVES)
Some covariates, C, may affect the treatment outcomes; therefore, taking covariates into considera-
tion seems to be necessary in the analysis of treatment effects.
We use a dummy variable D as the treatment indicator, C as the covariates of interest, and Z as
the outcome measure. For simplicity of notation, we consider D taking values 0 or 1, but the work
generalizes readily for multiple treatments. Since the difference between two treatment groups may
lie in the upper tail of the distributions, we model the τ -th quantile of Z given (D,C) as
QZ(τ |D,C) = α(τ) +Dδ(τ) + CγT (τ) = Xβ(τ), (2.1)
where the coefficients α, δ, and γ are τ -specific, X = (1, D,C), and β(τ) = (α(τ), δ(τ), γT (τ))T . In
this chapter, we use τ = 0.5 and 0.75 for simulation studies, and refer to Koenker (2005) for details
on the linear regression quantile specification.
Given data (Zi, Di, Ci) with Di = 1 for i = 1, · · · , n1 and Di = 0 for i = n1 + 1, · · · , n1 + n0,
we obtain the regression quantile coefficient αˆ(τ), δˆ(τ), and γˆ(τ) by quantile regression (Koenker
and Bassett, 1978). Then, let eˆi(τ) = Zi − αˆ(τ) −Diδˆ(τ) − CTi γˆ(τ) as the residuals from the τ -th
regression quantile. By contrast, we also write ei(τ) = Zi−α(τ)−Diδ(τ)−CTi γ(τ), which has zero
as the τ -th conditional quantile given (Di, Ci) due to (2.1).
The outcome, Zi, may be affected by both Di and Ci. To focus on the treatment effect, we need
to adjust the covariate effect. Let Yi = Zi − CTi γˆ(τ) be the covariate-adjusted outcome, and define
the empirical covariate-adjusted expected shortfall for the two groups as
COVESτ (d) =
∑
Di=d
wd,iYi, d = 0, 1,
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where wd,i = S−1d I(eˆi(τ) > 0) and Sd =
∑
Di=d
I(eˆi(τ) > 0). The quantity COVESτ (d) is the
average of the covariate-adjusted outcomes for group d that are above the τ -th quantile.
The proposed COVES test statistic for the hypothesis of no difference between the two treatment
groups is given as
TCOV ESτ (n1, n0) = COVESτ (1)− COVESτ (0). (2.2)
Note that, when covariates of interest, C, are excluded, the COVES test is reduced to the ES test.
Let C¯τ (d) and e¯τ (d) be the average of Ci and ei in group d that are above the τ -th regression
quantile, i.e.,
C¯τ (d) = S−1d
∑
Di=d
{CiI(eˆi(τ) > 0)},
e¯τ (d) = S−1d
∑
Di=d
{(Zi − α(τ)−Diδ(τ)− CTi γ(τ))I(eˆi(τ) > 0)}.
Then, the test statistic (2.2) can be written as
TCOV ESτ (n1, n0) = δ(τ)− (C¯τ (1)− C¯τ (0))T (γˆ(τ)− γ(τ)) + (e¯τ (1)− e¯τ (0)), (2.3)
which makes it relatively easy to establish the asymptotic normality of the test statistic as n1, n0 →
∞.
To estimate the variance of TCOV ESτ (n1, n0), let nd =
∑
i I(Di = d), fi be the conditional
density function of ei given (Di, Ci) evaluated at 0, and
C∗i = Ci − n−1d
∑
i
{CiI(Di = d)},
as the orthogonal components C relative to the treatment groups. In more general problems, we
can obtain C∗ by the Gram-Schmidt orthorgonalization of the design matrix. Furthermore, let
V = (n1 + n0)−1
∑
i
{eˆ2i (τ)I(eˆi(τ) > 0)} −
[
(n1 + n0)−1
∑
i
{eˆi(τ)I(eˆi(τ) > 0)}
]2
, (2.4)
Uf =
∑
i
(fiC∗i C
∗T
i ), and
s2n1,n0 = (1− τ)−2V (n−11 + n−10 ) + τ(1− τ)(C¯τ (1)− C¯τ (0))TU−1f {
∑
i
C∗i C
∗T
i }U−1f (C¯τ (1)− C¯τ (0)).
Lemma 2.1.1. If {(Zi, Di, Ci)} is a random sample satisfying ( 2.1), lim
n1, n0→∞
(n1+n0)−1Uf exists,
E ‖ Ci ‖31<∞, and fi are uniformly bounded away from 0 and infinity (L < fi < M, ∀i), then we
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have the Bahadur representation on γˆ(τ)
γˆ(τ)− γ(τ) = U−1f
∑
i
{C∗i ψτ (ei(τ))}+ op((n1 + n0)−1/2),
and the representation on e¯τ (d)
e¯τ (d) = {
∑
Di=d
I(ei(τ) > 0)}−1
∑
Di=d
{ei(τ)I(ei(τ) > 0)}+ op((n1 + n0)−1/2),
where Uf =
∑
i(fiC
∗
i C
∗T
i ), fi is the conditional density function of ei given (Di, Ci) evaluated at 0,
and C∗i = Ci − n−1d
∑
i{CiI(Di = d)}.
Proof of Lemma 2.1.1 The Bahadur representation for the quantile regression estimator, βˆ, is
(Koenker, 2005)
βˆ(τ)− β(τ) = D−1β (n1 + n0)−1
∑
i
xiψτ (ei(τ)) + (n1 + n0)−1/2Rn1+n0 ,
where βˆ(τ) = (αˆ(τ), δˆ(τ), γˆT (τ))T , β(τ) = (α(τ), δ(τ), γT (τ))T , xi = (1, Di, CTi )
T , ψτ (ei(τ)) =
τ − I(ei(τ) < 0), Dβ = lim
n1, n0→∞
(n1 + n0)−1
∑
i fixix
T
i , and Rn1+n0 = op(1).
For X = (1, D,C), we perform the Gram-Schmidt orthogonalization to get an orthogonal design
matrix X∗ = (1, D∗, C∗), where D∗i = Di − D¯0, C∗i = Ci − n−1d
∑
i CiI(Di = d), D¯0 is the overall
mean for D, and nd =
∑
i I(Di = d). Substituting the orthogonal design matrix X
∗ for X into the
expression of Dβ , we can get the diagonal matrix D∗β . Let Dγ denote the right-bottom corner of
D∗β . Then,
γˆ(τ)− γ(τ) = D−1γ (n1 + n0)−1
∑
i
{C∗i ψτ (ei(τ))}+ op((n1 + n0)−1/2)
= [{(n1 + n0)−1Uf}−1 + op(1)](n1 + n0)−1
∑
i
{C∗i ψτ (ei(τ))}+ op((n1 + n0)−1/2)
= U−1f
∑
i
C∗i ψτ (ei(τ)) + op(1)[(n1 + n0)
−1∑
i
{C∗i ψτ (ei(τ))}] + op((n1 + n0)−1/2)
= U−1f
∑
i
C∗i ψτ (ei(τ)) + op((n1 + n0)
−1/2),
where Uf =
∑
i(fiC
∗
i C
∗T
i ), fi is the conditional density function of ei given (Di, Ci) evaluated at 0,
and the last equality follows from the Central Limit Theorem for
∑
i{C∗i ψτ (ei(τ))}. 
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First, we prove the second equation in Lemma 2.1.1, which can be rewritten as
{
∑
Di=d
I(eˆi(τ) > 0)}−1
∑
Di=d
{ei(τ)I(eˆi(τ) > 0)} − {nd(1− τ)}−1
∑
Di=d
{ei(τ)I(ei(τ) > 0)} = op((n1 + n0)−1/2).
We do this by verifying the following two statements.
n−1d
∑
Di=d
I(eˆi(τ) > 0) = 1− τ + op((n1 + n0)−1/2), (2.5)
n−1d
[ ∑
Di=d
ei(τ){I(eˆi(τ) > 0)− I(ei(τ) > 0)}
]
= op((n1 + n0)−1/2). (2.6)
By the second inequality in Corollary 2.1 of Koenker (2005), we have
n−1d
∑
Di=d
I(eˆi(τ) > 0) ≤ 1− τ ≤ n−1d
∑
Di=d
I(eˆi(τ) > 0) + n−1d p,
and thus,
n−1d
∑
Di=d
I(eˆi(τ) > 0) = (1− τ) +Op(n−1d ) = (1− τ) + op((n1 + n0)−1/2).
By using Lemma 4.6 of He and Shao (1996), we will show (2.6). We introduce some notations first.
Let {xi, i ≥ 1} be independent random variables from probability distributions Fi,θ, i = 1, · · · , n,
with a common unknown parameter θ ∈ Θ, an open subset of Rm,m ≥ 1. Consider a score function
ψ(xi, θ) with λi(θ) = Eψ(xi, θ) and Λn(θ) =
∑n
i=1Eψ(xi, θ), and the M -estimator θˆn of θ0 that
satisfies
n∑
i=1
ψ(xi, θˆn) = o(δn),
where δn is a sequence of positive numbers. Let u(x, θ, d) = sup|ν−θ|≤d |ψ(x, ν)−ψ(x, θ)|, where | · |
is taken to be the sup norm defined as |θ| = max(|θ1|, · · · , |θm|), and Zn(ν, θ) = |
∑n
i=1(ψ(xi, ν) −
ψ(xi, θ)− λi(ν) + λi(θ))|. The conditions used in Lemma 4.6 of He and Shao (1996) are
(B1) For each fixed θ ∈ Θ, ψ(x, θ) is Borel measurable.
(B2) There exists θ0 ∈ Θ such that Λn(θ0) = 0 and |θˆn − θ0| → 0 almost surely as n→∞.
(B3) There exist r > 0, d0 > 0 and a sequence of positive numbers {ai, i ≥ 1} such that Eu2(xi, θ, d) ≤
a2i d
r for |θ − θ0| ≤ d0 and d ≤ d0.
(B4) A2n = O(An), where An =
∑n
i=1 a
2
i .
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(B5’) For some decreasing sequence of positive numbers dn such that dn = O(d2n) = o(1), max1≤i≤n u(xi, θ0, dn) =
O(A1/2n d
r/2
n (log n)−2) a.s.
Lemma 4.6 of He and Shao (1996)
Assume that (B1), (B3) and (B5’) are satisfied. Then we have
lim sup
n→∞
sup
|ν−θ0|≤dn
Zn(ν, θ0)
(Andrn + 1)1/2(log log(n+An))1/2
≤ C a.s.,
for some constant C <∞.
Let θ0 = 0, ψ(ei(τ), θ) = ei(τ){I(ei(τ) > xTi θ)− I(ei(τ) > 0)}, then
λi(θ) = Eψ(ei(τ), θ) = E
(
ei(τ){I(ei(τ) > xTi θ)− I(ei(τ) > 0)}
)
,
Znd(ν, θ0) =
∣∣ ∑
Di=d
{ψ(ei(τ), ν)− ψ(ei(τ), θ0)− λi(ν) + λi(θ0)}
∣∣
=
∣∣ ∑
Di=d
ei{I(ei(τ) > xTi ν)− I(ei(τ) > 0)}
+
∑
Di=d
E
(
ei(τ){I(ei(τ) > 0)− I(ei(τ) > xTi ν)}
)∣∣.
First, we have
n−1d
∑
Di=d
E
(
ei(τ){I(ei(τ) > 0)− I(ei(τ) > xTi ν)}
)
= n−1d
∑
Di=d
∫ xTi ν
0
ei(τ)f(ei(τ))dei(τ)
= n−1d
∑
Di=d
xTi νξif(ξi) ≤ n−1d
∑
Di=d
(xTi ν)
2f(ξi) = νT
( ∑
Di=d
f(ξi)xixTi /nd
)
ν
= O(‖ ν ‖22),
where ξi is between 0 and xTi ν. Therefore,
n−1d Znd(ν, θ0) =
∣∣n−1d ∑
Di=d
ei(τ){I(ei(τ) > xTi ν)− I(ei(τ) > 0)}
∣∣+O(‖ ν ‖22).
Conditions (B1), (B3) and (B5’) are checked as follows,
(B1) For each fixed θ, ψ(ei(τ), θ) = ei(τ){I(ei(τ) > xTi θ)− I(ei(τ) > 0)} is Borel measurable.
(B3) u(ei(τ), θ, d) = sup|ν−θ|≤d |ei(τ){I(ei(τ) > xTi ν)−I(ei(τ) > xTi θ)}| = sup|ν−θ|≤d |ei(τ)I(xTi ν <
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ei(τ) < xTi θ)| = |ei(τ)I(xTi ν∗ < ei(τ) < xTi θ)|, where ν∗ = θ − d(1, 1, sgn(CTi ))T . Therefore,
Eu2(ei(τ), θ, d) =
∫ xTi θ
xTi ν
∗
e2i (τ)f(ei(τ))dei(τ) ≤M(xTi θ)2 ‖ xi ‖1 d ≤Md20 ‖ xi ‖31 d,
where |θ| ≤ d0, and ‖ xi ‖1= 1 + Di+ ‖ Ci ‖1. Condition (B3) holds if we take r = 1, and
a2i =Md
2
0 ‖ xi ‖31.
(B5’) Let dnd = n
−1/2
d log nd, we have
max
1≤i≤nd
u(ei(τ), θ0, dnd)
A
1/2
nd d
1/2
nd (log nd)−2
=
max
1≤i≤nd
|ei(τ)I(xTi ν∗ < ei(τ) < 0)|
{Md20
∑
Di=d
‖ xi ‖31}1/2d1/2nd (log nd)−2
≤ dnd max1≤i≤nd ‖ xi ‖1
M1/2d0(
∑
Di=d
‖ xi ‖31)1/2d1/2nd (log nd)−2
= M−1/2d−10
max1≤i≤nd ‖ xi ‖1 n−1/2d
(
∑
Di=d
‖ xi ‖31 /nd)1/2
d1/2nd (log nd)
2 → 0 a.s.
as nd →∞,
where max1≤i≤nd ‖ xi ‖1≤ 2 + max1≤i≤nd ‖ Ci ‖1= O(n1/2d ) according to Lemma 11.2 in Owen
(2001, p.218),
∑
Di=d
‖ xi ‖31 /nd is bounded away from 0, and d1/2nd (log nd)2 = o(1).
Lemma 11.2 of Owen (2001)
Let Yi be independent random variables with a common distribution and E(Y 2i ) < ∞. Let Zn =
max1≤i≤n |Yi|. Then Zn = o(n1/2).
Because (B1), (B3) and (B5’) are satisfied, according to Lemma 4.6 of He and Shao (1996), we have
lim sup
nd→∞
sup
|ν−θ0|≤dnd
n−1d Znd(ν, θ0)
n−1d (Anddrnd + 1)
1/2(log log(nd +And))1/2
≤ C a.s.
The denominator is
n−1d (Andd
r
nd
+ 1)1/2(log log(nd +And))
1/2
= n−1d
(
Md20
∑
Di=d
‖ xi ‖31 n−1d (nddnd) + 1
)1/2( log log(nd +Md20 ∑
Di=d
‖ xi ‖31)
)1/2
= O(n−1d (ndn
−1/2
d log nd)
1/2(log log nd)1/2) = o((n1 + n0)−1/2),
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where
∑
Di=d
‖ xi ‖31 n−1d = O(1).
Therefore, the numerator is
n−1d Znd(ν, θ0) = op((n1 + n0)
−1/2),uniformly in {ν : |ν − θ0| ≤ dnd}.
Take ν = βˆ(τ)− β(τ), we have
n−1d
[ ∑
Di=d
ei(τ){I(eˆi(τ) > 0)− I(ei(τ) > 0)}
]
+O(‖ βˆ(τ)− β(τ) ‖22) = op((n1 + n0)−1/2),
where O(‖ βˆ(τ)− β(τ) ‖22) = O((n1 + n0)−1) = op((n1 + n0)−1/2).
Therefore, we have
n−1d
[ ∑
Di=d
ei(τ){I(eˆi(τ) > 0)− I(ei(τ) > 0)}
]
= op((n1 + n0)−1/2).
Theorem 2.1.1. Suppose that lim
n1, n0→∞
(n1 + n0)−1Uf exists, E ‖ Ci ‖31<∞, and fi are uniformly
bounded away from 0 and infinity. Under the null hypothesis that FZ|C,D=0 = FZ|C,D=1, we have
TCOV ESτ (n1, n0)/sn1,n0 → N(0, 1), as n1, n0 →∞.
Proof of Theorem 2.1.1 According to (2.3), Lemma 2.1.1, and δ(τ) = 0 under H0, we have
Tτ (n1, n0) =
∑
i
[(
I(Di = 1)− I(Di = 0)
){(1− τ)nd}−1ei(τ)I(ei(τ) > 0)− (C¯τ (1)− C¯τ (0))TU−1f C∗i ψτ (ei(τ))]
+op((n1 + n0)−1/2)
= T ∗(n1, n0) + op((n1 + n0)−1/2),
where
T ∗τ (n1, n0) =
∑
i
[(
I(Di = 1)− I(Di = 0)
){(1− τ)nd}−1ei(τ)I(ei(τ) > 0)− (C¯τ (1)− C¯τ (0))TU−1f C∗i ψτ (ei(τ))].
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We note that
E(T ∗τ (n1, n0)) = (1− τ)−1
{
n−11
∑
Di=1
E
(
ei(τ)I(ei(τ) > 0)
)− n−10 ∑
Di=0
E
(
ei(τ)I(ei(τ) > 0)
)}
= (1− τ)−1E(e(τ)I(e(τ) > 0))(1− 1) = 0.
Further, we have
var(T ∗τ (n1, n0)) = (1− τ)−2Var
(
e(τ)I(e(τ) > 0)
)
(n−11 + n
−1
0 ) (2.7)
+τ(1− τ)(C¯τ (1)− C¯τ (0))TU−1f {
∑
i
C∗i C
∗T
i }U−1f (C¯τ (1)− C¯τ (0)), (2.8)
which can be estimated by s2n1,n0 .
By the Central Limit Theorem, T ∗τ (n1, n0) is asymptotically normal with mean 0 and variance
(2.7). Using the results from Lemma 2.1.1 and TCOV ESτ (n1, n0) = T
∗
τ (n1, n0) + op((n1 + n0)
−1/2),
the proof is complete. 
To use the asymptotic normality for testing the null hypothesis of no treatment effects, we need
a consistent estimate of Uf . If ei(τ) follows a common distribution, then a kernel density estimate
can be used to estimate the common density at 0. If the conditional densities vary with Ci, it is
not possible to estimate each fi consistently, but Uf , a linear cobmination of the fi’s can still be
consistently estimated; see He et al. (2002) and Koenker (2005) for more details. For the simulations
in this chapter, the proposed test is carried out using a kernel density estimate, density, in R.
fˆi =
1
(n1 + n0)hn1+n0
∑
i
K(
0− eˆi(τ)
hn1+n0
),
where K is a kernel function, and hn1+n0 is a bandwidth, also called a smoothing parameter. In the
simulation, we used a rule of thumb bandwidth of a Gaussian kernel density provided by Silverman
(1986), that is
hn1+n0 = 0.9A(n1 + n0)
−1/5,
where A = min{standard deviation, interquartile range/1.34}.
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2.2 Simulations
Suppose that Z is the response variable under two treatments according to distributions F1 and
F0. We consider the problem of testing the null hypothesis that FZ|C,D=0 = FZ|C,D=1 versus the
two-sided alternative hypothesis when some covariates, C, may affect outcome measurements. For
simplicity, we consider C as a univariate covariate in the simulation. Five tests are considered to
detect the treatment effect, where the difference may lie in the upper tail of the distributions. The
0.5th/0.75th COVES test based on the difference in the covariate-adjusted expected loss above the
0.5th/0.75th quantile function, the 0.5th/0.75th ES test based on the difference in the expected loss
above the 0.5th/0.75th quantile without adjusting for covariates, and the t test based on the least
squares regression.
2.2.1 Normal Models
We consider data generated from
Zi = 5 + γCi + {1 + ηI(ei > 0)I(Di = 0)}ei
where ei ∼ N(0, 1), and η is either 0 (under the null hypothesis) or 1.35 (under the alternative
hypothesis). The coefficient γ and the distribution for the covariate Ci will be specified later.
Clearly, the control group (d = 0) has a heavier right tail. As we discuss in Subsection 1.4.1, when
η = 1.35, the error variance of the control group (d = 0) is about triple that of the treatment group
(d = 1) under this model. We will consider four scenarios for the effects of the covariate in the
analysis.
• Scenario 1, no covariate effect: we take Ci from N(2.5, 0.52), with γ = 0.
• Scenario 2, a common covariate effect: we take Ci from N(2.5, 0.52), with γ = 1.
• Scenario 3, a covariate distribution that varies with treatment groups: we take Ci from
N(2.5, 0.5) for d = 0, but from N(3.0, 0.52) for d = 1, with γ = 1.
• Scenario 4, a covariate distribution that has a scale change across treatment groups: we take
Ci from N(2.5, 0.52) for d = 0, but from N(2.5, 1.0) for d = 1, with γ = 1.
Type I Error and Histogram of p-values
A total ofM = 10, 000 Monte Carlo samples of size n1 = n0 = 50 are generated for Z under the null
hypothesis (with η = 0). From Table 2.1, Figure 2.1, and Figure 2.2, we find that the p-values for
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the ES test in Scenario 3 and Scenario 4 deviates a lot from the uniform distribution, which means
that the ES test is not appropriate. It is clear that when the covariate between two groups differs
a lot in location or scale, we can not ignore the covariate effect when we analyze the data.
Table 2.1: Type I error at sample size (n1, n0) = (50, 50) and nominal level 5% for for i.i.d errors
under normal covariates. The values in the table are in percentage.
Scenario 0.5th COVES test 0.75th COVES test 0.5th ES test 0.75th ES test t test
1 5.70 6.79 5.41 5.15 5.17
2 5.73 6.76 4.97 4.68 5.17
3 5.34 6.44 46.78 32.89 5.03
4 5.96 7.02 11.41 14.79 5.12
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Figure 2.1: Histograms of p-values in Scenario 3, a covariate distribution that varies with treatment
groups for i.i.d errors. (a) 0.5th COVES test. (b) 0.75th COVES test. (c) 0.5th ES test. (d) 0.75th
ES test. (e) t test.
Power Function
We will compare power functions for five tests, the 0.5th/0.75th COVES tests, the 0.5th/0.75th
ES tests, and the t test, and then provide the sample sizes needed for each test to reach power
0.9 at a given alternative. The grid is 10 for sample size, and we use smoothing splines to obtain
power curves. In Scenarios 3 and 4, the adjustment of the covariate is important. Because the ES
test is not valid, we will not include the ES test in these two scenarios. The results clearly show
the superiority of the COVES test. Consider Scenarios 1 and 2, when there is a covariate effect
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Figure 2.2: Histograms of p-values in Scenario 4, a covariate distribution that has a scale change
across treatment groups for i.i.d errors. (a) 0.5th COVES test. (b) 0.75th COVES test. (c) 0.5th
ES test. (d) 0.75th ES test. (e) t test.
(Scenario 2), the COVES test is more powerful. So, it’s more effective to compare the ES difference
after adjusting the covariates. Even when there is no covariate effect (Scenario 1), the COVES test
is nearly as good as the ES test. The t test required a sample size about twice as large.
Table 2.2: Comparisons of five tests. (a) Type I error at sample size (n1, n0) = (50, 50) and nominal
level 5% for for i.i.d errors. The values in the table are in percentage. (b) Sample size (n1, n0)
needed to reach power 0.9 at the alternative. In each scenario, the first row uses n1 = n0, and the
second row uses n1 = 2n0.
0.5th COVES test 0.75th COVES test 0.5th ES test 0.75th ES test t test
Scenario (a) (b) (a) (b) (a) (b)
1 5.70 (75, 75) 6.79 (51, 51) 5.41 (74, 74) 5.15 (50, 50) 5.17 (140, 140)
(140, 70) (92, 46) (136, 68) (94, 47)) (202, 101)
2 5.73 (76, 76) 6.76 (51, 51) 4.97 (83, 83) 4.68 (59, 59) 5.17 (140, 140)
(138, 69) (92, 46) (148, 74) (110, 55) (202, 101)
3 5.34 (88, 88) 6.44 (59, 59) 46.78 32.89 5.03 (177, 177)
(152, 76) (100, 50) (240, 120)
4 5.96 (77, 77) 7.02 (51, 51) 11.41 14.79 5.12 (141, 141)
(140, 70) (96, 48) (202, 101)
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Figure 2.3: Statistical powers of five tests as functions of sample size n1 = n0 = n for i.i.d errors.
(a) Scenario 1. (b) Scenario 2. (c) Scenario 3. (d) Scenario 4.
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2.2.2 Targeted Study on TSS
We use the same data discussed in Subsection 1.4.2, but use the baseline TSS as the covariate in the
analysis. For the control group, the baseline TSS is generated in such a way that the quantiles of the
baseline TSS in the two groups are the same and the outcome measurement is simulated according
to the same two scenarios discussed in Subsection 1.4.2.
Table 2.3 reports the type I errors at a total of M = 10, 000 Monte Carlo samples of size
n1 = n0 = 100. It also reports the sample sizes needed to reach power of 0.90 in each scenario under
two design conditions: n1 = n0 and n1 = 2n0, respectively. The results clearly show the baseline
TSS does not play a significant role, so the statistical power for detecting the treatment effect has
no gain (0.75th quantile) or just gain a little bit (0.5th quantile) by adjusting the covariate in the
analysis. However, the COVES test is clearly outperforming the t test based on the least squares
regression, and the latter would require a trial that is more than double in size. In both scenarios,
the 0.75th COVES/ES tests outperform the 0.5th COVES/ES test because the difference between
two groups lies in the upper tail of the 0.65th and 0.75th quantiles, respectively.
The power functions for these tests in each scenario are shown in Figure 2.4 with sample sizes
up to n1 = n0 = 350. The grid is 10 for sample size, and we use smoothing splines to obtain power
curves. The t test required more than double sample size to reach power 0.9.
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Figure 2.4: Statistical powers of five tests in reference with the TSS data with agreement up to the
(a) 0.65th quantile and (b) 0.75th quantile, as functions of sample size n1 = n0 = n.
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Table 2.3: Comparisons of five tests. (a) Type I error at sample size (n1, n0) = (100, 100) and
nominal level 5%. The values in the table are in percentage. (b) Sample size (n1, n0) needed to
reach power 0.9. In each scenario, the first row uses n1 = n0, and the second row uses n1 = 2n0.
0.5th COVES test 0.75th COVES test 0.5th ES test 0.75th ES test t test
Scenario (a) (b) (a) (b) (a) (b)
1 4.85 (129, 129) 6.78 (120, 120) 5.41 (170, 170) 4.96 (110, 110) 4.99 (306, 306)
(202, 101) (172, 86) (276, 138) (158, 79) (450, 225)
2 4.85 (145, 145) 6.78 (122, 122) 5.41 (188, 188) 4.96 (130, 130) 4.99 (305, 305)
(250, 125) (246, 123) (322, 161) (230, 115) (442, 221)
2.3 Conclusion
We have proposed a new test to detect treatment effects where the difference between two treatment
groups may lie in the upper tail of the distributions. The χ2 test mentioned in Section 1.4 is difficult
to implement if we need to adjust for covariates. Besides, there has been no agreeable cutoff point
for dichotomization. The t test based on the least squares regression focuses on the conditional
mean, which is not powerful for detecting the difference appearing in the tail. In contrast, we take
the covariate-adjusted outcomes above the τ -th quantile regression line to construct the COVES test
statistic, which compares the covariate-adjused expected shortfalls between two groups. Empirical
studies illustrate that the proposed test has a clear advantage in reducing sample sizes in clinical
trials.
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Chapter 3
Generalized Covariate-adjusted
Expected Shortfall Test
The COVES test adjusts for covariates, and is shown to be valid for i.i.d (independent and identically
distributed) error models. We show that the COVES test is valid when the covariates have the same
means across treatments in non-iid errors. However, in a non-randomized design and non-i.i.d error
model, the covariates may not have the same means across treatments. The COVES test is not valid
for this scenario and we propose the Generalized Covariate-adjusted Expected Shortfall (q.COVES)
to generalizes the COVES test to more general models.
Given data (Zi, Di, Ci) with Di = 1 for i = 1, · · · , n1 and Di = 0 for i = n1 + 1, · · · , n1 + n0.
Consider a quantile model
Zi = α(ui) +Diδ(ui) + CTi γ(ui) = x
T
i β(ui) (3.1)
= α(τ) +Diδ(τ) + CTi γ(τ) + ei(τ) = x
T
i β(τ) + ei(τ),
where xi = (1, Di, CTi )
T , β(u) = (α(u), δ(u), γT (u))T , ei(τ) are independent but not identically
distributed, with
ui ∼ U(0, 1),
α(ui) = Φ−1(ui),
ei(τ) = (α(ui)− α(τ)) +Di(δ(ui)− δ(τ)) + CTi (γ(ui)− γ(τ)) = xTi (β(ui)− β(τ)),
where Φ is the cumulative distribution function of the standard normal distribution. Here, ui is the
quantile level in the conditional distribution of Zi given (Di, Ci), and {ei(τ) > 0} is equivalent to
{ui > τ} given (Di, Ci). The distribution for the covariates Ci will be specified later. We consider
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the hypothesis
H0 : δ(u) = 0 for all u ∈ (0, 1)
v.s. H1 : δ(u) =
 a(u− 1/2) , if u > 1/20 , otherwise.
for some a > 0. Let βˆ(τ) = (αˆ(τ), δˆ(τ), γˆT (τ)) be the regression quantile coefficients at the τ -th
quantile level, Sd be the number of Zi in group d that are above the τ -th regression quantile, eˆi(τ)
be the residuals from the τ -th conditional quantile given (Di, Ci). Then
Sd =
∑
Di=d
I(eˆi(τ) > 0).
Let
Yi = Zi − αˆ(τ)− CTi γˆ(τ) = (α(ui)− αˆ(τ)) +Diδ(ui) + CTi (γ(ui)− γˆ(τ))
= x˜Ti (β(ui)− βˆ(τ)) +Diδ(ui)
be the covariate-adjusted outcome, where x˜i = (1, 0, CTi )
T . We assign each covariate-adjusted
outcome, Yi, a weight qd,i to develop a new COVES test statistic such that the mean difference in
Ci will be accounted for. Here, the generalized COVES (abbreviated as q.COVES) test statistic is
T q.COV ESτ (n1, n0) =
∑
Di=1
wd,iqd,iYi −
∑
Di=0
wd,iqd,iYi, (3.2)
where
wd,i = S−1d I(eˆi(τ) > 0).
According to the Bahadur representation of the quantile estimator (Koenker, 2005), we have
βˆ(τ)− β(τ) = H−1n1+n0(n1 + n0)−1
∑
i
xiψτ (ei(τ)) + (n1 + n0)−1/2Rn1+n0 ,
where βˆ(τ) = (αˆ(τ), δˆ(τ), γˆT (τ))T , β(τ) = (α(τ), δ(τ), γT (τ))T , xi = (1, Di, CTi )
T , ψτ (ei(τ)) =
τ − I(ei(τ) < 0), fi is the conditional density function of ei(τ) given (Di, Ci) evaluated at 0, the
Hessian matrix Hn1+n0 = limn1, n0→∞
(n1+n0)−1
∑
i fixix
T
i , and the remainder term Rn1+n0 = op(1).
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The matrix Hn1+n0 can be consistently estimated by the sparsity estimation method (Hendricks
and Koenker, 1992), which uses
fˆi = 2hn1+n0/{xTi (βˆ(τ + hn1+n0)− βˆ(τ − hn1+n0))},
where the bandwidth
hn1+n0 = (n1 + n0)
−1/5
[
4.5φ4(Φ−1(τ))
(2Φ−1(τ)2 + 1)2
]1/5
.
Let
H−1 = (
∑
i
fixix
T
i )
−1.
We have,
βˆ(τ)− β(τ) = H−1
∑
xiψτ (ei(τ)) + op((n1 + n0)−1/2). (3.3)
Theorem 3.0.1. Suppose that lim
n1, n0→∞
(n1+n0)−1H exists. Under the null hypothesis that FZ|C,D=0 =
FZ|C,D=1, we have
T q.COV ESτ (n1, n0)/sn1,n0 → N(0, 1), as n1, n0 →∞,
where
s2n1,n0 = (1− τ)−2
∑
i
n−2d q
2
d,ix˜
T
i Vβx˜i + τ(1− τ)(Xqτ (1)−Xqτ (0))TH−1{
∑
i
xix
T
i }H−1(Xqτ (1)−Xqτ (0))
−2τ(1− τ)−1
∑
i
{
(I(Di = 1)− I(Di = 0))n−1d qd,ix˜Ti EβxTi H−1(Xqτ (1)−Xqτ (0))
}
,
x˜i = (1, 0, CTi )
T ,
Xqτ (d) = S
−1
d
∑
Di=d
qd,ix˜iI(eˆi(τ) > 0),
Eβ = (n1 + n0)−1
∑
i
{(βˆ(ui)− βˆ(τ))I(ui > τ)}, and
Vβ = (n1 + n0)−1
∑
i
{(βˆ(ui)− βˆ(τ))(βˆ(ui)− βˆ(τ))T I(ui > τ)} − E2β .
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Proof of Theorem 3.0.1 According to (3.2), (3.3), and δ(u) = 0 under H0, we have
T q.COV ESτ (n1, n0) =
∑
i
{
(I(Di = 1)− I(Di = 0))S−1d qd,ix˜Ti (β(ui)− βˆ(τ))I(eˆi(τ) > 0)
}
=
∑
i
[
(I(Di = 1)− I(Di = 0)){(1− τ)nd}−1qd,ix˜Ti (β(ui)− β(τ))I(ui > τ)
−(Xqτ (1)−Xqτ (0))TH−1xiψτ (ei(τ))
]
+ op((n1 + n0)−1/2)
= T ∗(n1, n0) + op((n1 + n0)−1/2),
where
x˜i = (1, 0, CTi )
T , Xqτ (d) = S
−1
d
∑
Di=d
qd,ix˜iI(eˆi(τ) > 0), and
T ∗(n1, n0) =
∑
i
[
(I(Di = 1)− I(Di = 0)){(1− τ)nd}−1qd,ix˜Ti (β(ui)− β(τ))I(ui > τ)
−(Xqτ (1)−Xqτ (0))TH−1xiψτ (ei(τ))
]
.
We note that
E(T ∗(n1, n0)) = (1− τ)−1
(
n−11
∑
Di=1
qd,ix˜i − n−10
∑
Di=0
qd,ix˜i
)T
E
(
(β(u)− β(τ))I(u > τ)).
If covariates have the same means across treatments, then
n−11
∑
Di=1
x˜i = n−10
∑
Di=0
x˜i.
We have E(T ∗(n1, n0)) = 0 with the choice of qd,i = 1 for all i. In this scenario, the q.COVES
test reduces to the COVES test. On the other hand, if any covariate has different means across
treatments, then
n−11
∑
Di=1
x˜i 6= n−10
∑
Di=0
x˜i.
We have E(T ∗(n1, n0)) 6= 0 with the choice of qd,i = 1 for all i. To ensure E(T ∗(n1, n0)) = 0, we
need to choose weights to satisfy
n−11
∑
Di=1
qd,ix˜i = n−10
∑
Di=0
qd,ix˜i. (3.4)
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The choice of qd,i will be discussed in Section 3.1.1 to 3.1.3. Further, we have
V ar(T ∗(n1, n0)) = (1− τ)−2
∑
i
n−2d q
2
d,ix˜
T
i Var
(
(β(u)− β(τ))I(u > τ))x˜i
+τ(1− τ)(Xqτ (1)−Xqτ (0))TH−1{
∑
i
xix
T
i }H−1(Xqτ (1)−Xqτ (0))
−2τ(1− τ)−1
∑
i
{
(I(Di = 1)− I(Di = 0))n−1d qd,ix˜Ti E
(
(β(u)− β(τ))I(u > τ))xTi H−1
(Xqτ (1)−Xqτ (0))
}
,
which can be estimated by s2n1,n0 . We estimate the quantile level for each observation, ui, by finding
the level so that the quantile regression fit under H1 passes the observation. For the ith observation,
i = 1, · · · , n1+n0, the corresponding ui is its qunatile level. Finally, E
(
(β(u)− β(τ))I(u > τ)) and
Var
(
(β(u) − β(τ))I(u > τ)) can be estimated by Eβ and Vβ , respectively. By the Central Limit
Theorem, and T q.COV ESτ (n1, n0) = T
∗
τ (n1, n0) + op((n1 + n0)
−1/2), the proof is complete. 
There are two other ways to calculate the variance of T ∗(n1, n0). Let
Adi = (I(Di = 1)− I(Di = 0)){(1− τ)nd}−1qd,ix˜Ti (βˆ(ui)− βˆ(τ))I(ui > τ)
−(Xqτ (1)−Xqτ (0))TH−1xiψτ (ei(τ)).
We have
Tˆ ∗(n1, n0) =
∑
i
Adi
=
∑
Di=1
A1i +
∑
Di=0
A0i,
and V ar(T ∗(n1, n0)) can be estimated either by
∑
i
A2di − (n1 + n0)−1(
∑
i
Adi)2.
or
1∑
d=0
{
∑
Di=d
A2di − n−1d (
∑
Di=1
Adi)2}.
According to the simulation results, we find that the the variance estimates from these two
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methods are not very stable. Therefore, we use s2n1,n0 for the variance calculation.
3.1 Simulations
Suppose that Z is the response variable under two treatments with distributions F1 and F0, respec-
tively. We consider the problem of testing the null hypothesis that FZ|C,D=0 = FZ|C,D=1 versus
the two-sided alternative hypothesis, where the covariates C may affect treatment outcomes. For
simplicity, we consider C as a univariate covariate in the simulation. We provide three studies for
i.i.d error and non-i.i.d error models. The first study is i.i.d errors with normal covariates. This
study shows that the COVES test is still valid under non-randomized design if the errors are i.i.d.
The other two studies involve non-i.i.d errors with discrete and normal covariates, respectivelty.
These two studies show that the COVES test is not valid in non-randomized design for non-i.i.d
errors. Koenker (2010) proposed rank tests designed for heterogeneous treatment effect models. The
rank tests use the regression rankscores introduced by Gutenbrunner and Jureckova (1992) to tackle
covariate effects. In our simulations, we will include the rank test for comparison.
We will compare the 0.5th/0.75th q.COVES tests based on the difference in the q-weighted
covariate-adjusted expected loss above the 0.5th/0.75th quantile function, the 0.5th/0.75th COVES
tests based on the difference in the covariate-adjusted expected loss above the 0.5th/0.75th quantile
function, the 0.5th/0.75th rank (aka, trimmed Wilcoxon) tests based on the difference in the inte-
grated rankscore above 0.5th/0.75th quantile, and the t test based on the least squares regression.
3.1.1 Simulation Studies for i.i.d Errors with Normal Covariates
Thus far in this chapter, we have proposed the q.COVES test that works in non-i.i.d error models.
There are several ways to choose weights to satisfy (3.4). We will provide a way later in Section
3.1.1 to 3.1.3. In this section, we show that both q.COVES and COVES tests work in i.i.d error
models.
We consider data generated from
Zi = 5 + γCi + {1 + ηI(ei > 0)I(Di = 0)}ei
where ei ∼ N(0, 1), and η is 0 under the null hypothesis. The coefficient γ and the distribution for
the covariate Ci will be specified later. We consider four scenarios for the effects of the covariate in
the analysis.
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• Scenario 1, no covariate effect: we take Ci from N(10, 2.52), with γ = 0.
• Scenario 2, a common covariate effect: we take Ci from N(10, 2.52), with γ = 1.
• Scenario 3, a covariate distribution that varies with treatment groups: we take Ci from
N(13, 2.52) for d = 1, but from N(10, 2.52) for d = 0, with γ = 1.
• Scenario 4, a covariate distribution that has a scale change across treatment groups: we take
Ci from N(10, 32) for d = 1, but from N(10, 2.52) for d = 0, with γ = 1.
The choice of weights, qd,i, assigns more weights to the overlap of the two groups of covariates.
For each scenario, we partition the overlap, I = [a1, a2], into three subintervals with equal length,
I1, I2, and I3. We assign weights 1 to the values of covariates outside the overlap, i.e., (−∞, a1) and
(a2,∞). Table 3.1 provides the weights for each scenario. The values of l and k are determined by
(3.4).
Table 3.1: The choice of weights for all scenarios. The covariates from two groups overlap on
I = [a1, a2] = I1 ∪ I2 ∪ I3.
values of covariates
(−∞, a1) I1 I2 I3 (a2,∞)
d=1 1 l3 l2 l 1
d=0 1 k k2 k3 1
Type I Error
A total of M = 10, 000 Monte Carlo samples of size n1 = n0 = 100 are generated for Z under the
null hypothesis (with η = 0). Table 3.2 shows that the Type I errors stay around the nominal level
5%, although q.COVES is a little liberal.
Table 3.2: Type I error at sample size (n1, n0) = (100, 100) and nominal level 5% for i.i.d errors.
The values in the table are in percentage.
Scenario 0.5th q.COVES test 0.75th q.COVES test 0.5th COVES test 0.75th COVES test
1 5.94 6.73 5.30 5.64
2 5.89 6.81 5.33 5.71
3 6.46 7.85 5.33 5.71
4 6.03 6.69 5.33 5.75
Scenario 0.5th rank test 0.75th rank test t test
1 4.96 5.05 5.19
2 4.96 5.05 5.19
3 4.76 5.14 5.37
4 5.00 5.14 5.23
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Power Function of η
We compare power functions for these seven tests with η up to 1 (with grid 0.25) given sample size
n1 = n0 = 100 and Type I error calibrated to the nominal level 5%. We use smoothing splines to
obtain power curves. The results in Figure 3.1 clearly show the superiority of the COVES test.
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Figure 3.1: Statistical powers of seven tests as functions of η for i.i.d errors. (a) Scenario 1. (b)
Scenario 2. (c) Scenario 3. (d) Scenario 4.
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3.1.2 Simulation Studies for non-i.i.d Errors with Discrete Covariates
For simplicity, we assume discrete covariates first and then generalize to continuous covariates in
the next section for non-i.i.d error models.
We consider data generated from (3.1) with four scenarios for the effects of the covariate in the
analysis.
• Scenario 1, no covariate effect: we take Ci from {1, 2, 3} with probability {0.2, 0.6, 0.2} and
γ(u) = 0.
• Scenario 2, a common covariate effect: we take Ci from {1, 2, 3} with probability {0.2, 0.6, 0.2}
and γ(u) = 1.
• Scenario 3, a covariate distribution that varies with treatment groups: we take Ci from
{2, 3, 10} with probability {0.2, 0.5, 0.3} for d = 1, but from {1, 2, 3} with probability {0.2, 0.6, 0.2}
for d = 0. γ(u) = 100u.
• Scenario 4, a covariate distribution that has a scale change across treatment groups: we take
Ci from {1, 2, 3} with probability {0.2, 0.3, 0.5} for d = 1, but from {2, 3, 4} with probability
{0.8, 0.1, 0.1} for d = 0. γ(u) = 100u.
The choice of weights, qd,i, assigns more weights to the common values of the two groups of
covariates. For both groups, we assign weights 1 to the unique values in each of the two groups of
covariates. Table 3.3 provides the weights for each scenario, where l and k are determined by (3.4).
Note that, for Scenarios 1 and 2, we tried weights l3, l2, and l, and k, k2, and k3 for the values of
covariates 1, 2, and 3 for d = 1 and d = 0, respectively, but no solutions to (3.4) were found.
Table 3.3: The choice of weights for each scenario.
Scenario 1 and 2 Scenario 3 Scenario 4
values of covariates values of covariates values of covariates
1 2 3 1 2 3 10 1 2 3 4
d=1 l4 l3 l l2 l 1 l2 l 1
d=0 k k3 k4 1 k k2 1 k k2
Type I Error
A total ofM = 10, 000 Monte Carlo samples of size n1 = n0 = 100 are generated for Z under the null
hypothesis (with δ(u) = 0). From Table 3.4 and Figure 3.2, we find that the COVES test and the t
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test are not appropriate when the covariate between two groups differs in means. Heteroscedasticity
is pronounced in scenario 3; therefore, the t test is not valid.
Table 3.4: Type I error at sample size (n1, n0) = (100, 100) and nominal level 5% for non-i.i.d errors
with discrete covariates. The values in the table are in percentage.
Scenario 0.5th q.COVES test 0.75th q.COVES test 0.5th COVES test 0.75th COVES test
1 5.88 6.35 5.12 5.38
2 5.99 6.41 5.32 5.52
3 5.14 5.49 49.84 25.61
4 5.31 5.47 4.55 5.77
Scenario 0.5th rank test 0.75th rank test t test
1 4.82 4.91 5.02
2 4.82 4.91 5.02
3 5.50 5.96 0.43
4 5.41 5.30 5.48
Power Function of a
We compare power functions for these seven tests with a up to 4 (with grid 0.5) for Scenario 1
and Scenario 2, and up to 200 (with grid 25) for Scenario 3 and Scenario 4, given the sample size
n1 = n0 = 100, and Type I error calibrated to the nominal level 5%. We use smoothing splines
to obtain power curves. The results in Figure 3.3 clearly show the superiority of the generalized
COVES test in all scenarios.
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Figure 3.2: Histograms of p-values in Scenario 3 for non-i.i.d errors with discrete covariates. (a)
0.5th q.COVES test. (b) 0.75th q.COVES test. (c) 0.5th COVES test. (d) 0.75th COVES test. (e)
0.5th rank test. (f) 0.75th rank test. (g) t test.
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Figure 3.3: Statistical powers of seven tests as functions of a for non-i.i.d errors with discrete
covariates. (a) Scenario 1. (b) Scenario 2. (c) Scenario 3. (d) Scenario 4.
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3.1.3 Simulation Studies for non-i.i.d Errors with Normal Covariates
We consider data generated from (3.1) with four scenarios for the effects of the covariate in the
analysis.
• Scenario 1, no covariate effect: we take Ci from N(10, 2.52), with γ(u) = 0.
• Scenario 2, a common covariate effect: we take Ci from N(10, 2.52), with γ(u) = 1.
• Scenario 3, a covariate distribution that varies with treatment groups: we take Ci from
N(13, 2.52) for d = 1, but from N(10, 2.52) for d = 0, with γ(u) = 100u.
• Scenario 4, a covariate distribution that has a scale change across treatment groups: we take
Ci from N(10, 32) for d = 1, but from N(10, 2.52) for d = 0, with γ(u) = 100u.
For each scenario, the choice of weights is the same as Table 3.1.
Type I Error
A total of M = 10, 000 Monte Carlo samples of size n1 = n0 = 100 are generated for Z under the
null hypothesis (with δ(u) = 0). From Table 3.5 and Figure 3.4, we find that the COVES test is not
appropriate when the covariate between two groups differs in means.
Table 3.5: Type I error at sample size (n1, n0) = (100, 100) and nominal level 5% for non-i.i.d errors
with normal covariates. The values in the table are in percentage.
Scenario 0.5th q.COVES test 0.75th q.COVES test 0.5th COVES test 0.75th COVES test
1 5.92 6.74 5.39 5.60
2 6.03 6.70 5.28 5.48
3 5.60 6.45 17.90 7.14
4 5.53 5.60 5.01 5.11
Scenario 0.5th rank test 0.75th rank test t test
1 5.13 4.91 5.04
2 5.13 4.91 5.04
3 4.66 4.73 4.93
4 5.04 4.89 5.21
Power Function of a
We compare power functions for these seven tests with a up to 4 (with grid 0.5) for Scenario 1
and Scenario 2, and up to 800 (with grid 100) for Scenario 3 and Scenario 4, given the sample size
n1 = n0 = 100, and Type I error calibrated to the nominal level 5%. We use smoothing splines
to obtain power curves. The results in Figure 3.5 clearly show the superiority of the generalized
COVES test in all scenarios.
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Figure 3.4: Histograms of p-values in Scenario 3 for non-i.i.d errors with normal covariates. (a)
0.5th q.COVES test. (b) 0.75th q.COVES test. (c) 0.5th COVES test. (d) 0.75th COVES test. (e)
0.5th rank test. (f) 0.75th rank test. (g) t test.
3.2 Future Work
So far, we have provided a way to assign weights for the generalized covariate-adjusted expected
shortfall test. As future work, we will investigate the optimal weights so that the q.COVES is as
powerful as possible.
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Figure 3.5: Statistical powers of seven tests as functions of a for non-i.i.d errors with noraml covari-
ates. (a) Scenario 1. (b) Scenario 2. (c) Scenario 3. (d) Scenario 4.
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Chapter 4
Bayesian Inference for Conditional
Autoregressive Value at Risk
4.1 Introduction
The recent financial crisis has highlighted the importance of risk management. Value at Risk (VaR)
is simply a quantile of the loss distribution of a portfolio within a given time period (k) and a
confidence level (1 − θ). For example, at k = 14 days and the 0.99th quantile, if the 1% VaR is 5
million dollars, then there is 1% chance of a loss exceeding 5 million dollars over a period of two
weeks. VaR becomes a popular measure of risk used by financial institutions because it is just a
single number and is easy to understand. Many firms use overnight (k = 1 day) VaRs for internal
management, and the two-week (k = 14 days) VaRs for disclosure to regulators. For example, J.P.
Morgan discloses its daily 5% VaRs, and Bankers Trust discloses the daily 1% VaRs. Central bank
regulators use VaR in determining the capital a bank is required to keep.
Accurate VaR estimation can help financial institutions maintain appropriate capital levels to
cover the risk from the corresponding portfolio. A Variance-Covariance approach is often used, and
is based on the normality assumption on the return distributions. Let Lt,k = −yt,k be the k-period
loss, where yt,k is the k-period return defined as the sum of k period successive returns starting from
time t, and the daily returns are computed as the difference of the log of successive prices. Assume
that yt,k is normally distributed with mean µt,k and variance σ2t,k. According to the definition of
VaR, P (Lt,k > VaRt,k,θ) = P (yt,k < −VaRt,k,θ) = θ, thus we have VaRt,k,θ = −(µt,k +Φ−1(θ)σt,k),
where Φ(·) is the cumulative distribution function of the standard normal distribution. Assume that
µt,k = 0, and that the returns are uncorrelated with the same variance, then a k-period variance
forecast σˆ2t,k is the sum of k period variances, i.e., kσˆ
2
t+1. The Variance-Covariance approach is
easy to implement because we just need to estimate the one-step-ahead variance forecast, σˆ2t+1, by
the Exponentially Weighted Moving Average (EWMA) model or the Generalized Autoregressive
Conditional Heteroscedasticity (GARCH) model (Bollerslev, 1986).
However, Hull and White (1998) point out that the distributions of returns have positive excess
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kurtosis, i.e., the distributions have heavier tails than the normal distributions. Motivated by this
observation, distribution-free approaches to estimate VaR seem to be more appropriate.
The quantile regression approach developed by Koenker and Bassett (1978) provides an estimate
for a specific quantile on return. Suppose that we observe a vector {xt, yt}Tt=1, where xt is a p-
dimensional explanatory variable, and yt is the return at time t. Assume that the θ-th conditional
quantiles of yt given xt is xTt β(θ), where θ ∈ (0, 1). Then, VaR at time t with a given confidence
level 1− θ and a holding period 1 day, VaRt,θ(β), equals −xTt β(θ). The θ-th regression quantile, βˆ,
can be solved by a minimization problem
min
β
RQ(β, θ),
where
RQ(β, θ) =
T∑
t=1
{θ − I(yt < −VaRt,θ(β))}{yt +VaRt,θ(β)} (4.1)
is the quantile loss function, and I denotes the indicator function. Taylor (1999) presents a con-
ditional quantile model to estimate the VaR over the holding period, k. Candidate explanatory
variables are first chosen from any two products of 1, k, k1/2, k2, σˆt+1, and σˆ2t+1, where σˆt+1 is a
GARCH(1, 1) (Bollerslev, 1986) one-step-ahead volatility forecast. He chooses explanatory vari-
ables with the largest Pseudo-R2
Pseudo-R2 = 1− Sum of Weighted Deviations about Estimated Quantile
Sum of Weighted Deviations about Raw Quantile
= 1− RQ(βˆ, θ)
RQ(θ)
, (4.2)
where the raw quantile defined as Qˆ(θ) is the θ-th quantile of {yt}Tt=1, and RQ(θ) =
T∑
t=1
{θ− I(yt <
Qˆ(θ))}{yt − Qˆ(θ)}.
Engle and Manganelli (2004) propose several conditional autoregressive value at risk (CAViaR)
models. Consider the model for the return, yt, at time period t, as
yt = Quantθ(yt−1, xt−1, · · · , y1, x1;β) + t,θ
≡ Quantt,θ(β) + t,θ, t = 1, · · · , T, (4.3)
where xt denotes a vector of explanatory variables, Quantt,θ(β) ≡ Quantθ(yt−1, xt−1, · · · , y1, x1;β)
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denotes the θ-th conditional quantile of return at time t, the θ-th conditional quantile of the error
term given Ωt is zero, i.e., Quantθ(t,θ|Ωt) = 0, and Ωt = (yt−1, xt−1, · · · , y1, x1, Quant1,θ(β)) is the
information set available before time t.
Assume VaRt,θ(β) follows a generic conditional autoregressive value at risk (CAViaR) model
VaRt,θ(β) = β1 +
q∑
i=1
βi+1VaRt−i,θ(β) +
r∑
j=1
βq+j+1l(xt−j),
where p = q + r + 1 is the dimension of β, and l is a function of lagged explanatory variables. A
natural choice of xt−j is lagged returns.
Let Lt = −yt equal the loss at time t. Because P (Lt > VaRt,θ(β)) = P (yt < −VaRt,θ(β)) = θ ,
we have VaRt,θ(β) = −Quantt,θ(β) by (4.3).
Four specific CAViaR models used by Engle and Manganelli (2004) are:
Symmetric Absolute Value (SAV)
VaRt,θ(β) = β1 + β2VaRt−1,θ(β) + β3|yt−1|;
Asymmetric Slope (AS)
VaRt,θ(β) = β1 + β2VaRt−1,θ(β) + β3(yt−1)+ + β4(yt−1)−,
where (x)+ = max(x, 0), (x)− = −min(x, 0);
Indirect GARCH(1, 1)
VaRt,θ(β) = (β1 + β2VaR2t−1,θ(β) + β3y
2
t−1)
1/2;
and Adaptive,
VaRt,θ(β1) = V aRt−1,θ(β1) + β1[{1 + exp(G{yt−1 +VaRt−1,θ(β1)})}−1 − θ],
where G is some positive finite number. Generally, the parameter G could be estimated. For
simplicity, Engle and Manganelli (2004) set G = 10.
All four models assume the dependence of VaR on the past return yt−1. In the SAV and the
indirect GARCH models, the past return is assumed to have a symmetric impact on the current
VaR, i.e., past returns with the same magnitude but different sign will have the same impact on
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VaR. On the other hand, the AS model allows an asymmetric impact.
All four models assume the dependence of VaR on the lagged VaR. In the previous three models,
the corresponding coefficient of VaRt−1,θ needs to be learned from the data, while the Adaptive
model assumes a unit coefficient. The second term in the Adaptive model is a smoothed version
of its own limit (when G → ∞), a step function β1{I(yt−1 ≤ −VaRt−1,θ(β1)) − θ}. The intuition
behind this model is that when the past loss is less than the past VaR, i.e., yt−1 > −VaRt−1,θ(β1),
we should decrease the current VaR slightly by the amount of θβ1; when the past loss is exceeding
or equal to the past VaR, i.e., yt−1 ≤ −VaRt−1,θ(β1), we should increase the current VaR by the
amount of (1− θ)β1.
Let Hits
Hitst(β) ≡ I(yt < −VaRt,θ(β))− θ. (4.4)
Clearly, the expected value of Hitst(β) is 0. The θ-th regression quantile, βˆ, is solved by minimizing
RQ(β, θ) in (4.1). Smaller values of |Hitst(βˆ)| over a period of time are needed for βˆ to be a good
estimate. Engle and Manganelli (2004) estimate βˆ by the Nelder-Mead simplex algorithm and the
quasi-Newton method, and evaluate the performance of a CAViaR model by empirical Hits in-sample
(HitsIS) and empirical Hits out-of-sample (HitsOOS).
This chapter contrasts the frequentist approach with a Bayesian approach on the CAViaR models
for providing the entire posterior distributions of interests in parameter, VaR, Hits in-sample, and
Hits out-of-sample. Engle and Manganelli’s method of estimation may not find the optimal quantile
estimates that minimize the quantile loss function (4.1) because smaller values were attained by the
Bayesian approach. Importantly, the performance of CAViaR models is better using the Bayesian
approach than Engle and Manganelli’s approach based on Hits in-sample and Hits out-of-sample
criteria. The remainder of this chapter is organized as follows. We provide the working likelihood for
the error term, the prior, and the proof of the property of the posterior. Next, we propose an MCMC
strategy along with a block algorithm for the Bayesian inference. In the end, we present empirical
investigations in both a stable period and volatile period to show that the Bayesian approach adds
value to the original estimation method of Engle and Manganelli (2004) in terms of both parameter
estimation and model fitting.
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4.2 Bayesian Modeling for VaR
In this Section, we provide the Bayesian settings on the CAViaR models.
4.2.1 Working Likelihood
Consider an asymmetric Laplace density as a working conditional density function for the error term
f(t,θ|Ωt) = θ(1− θ)
σ
exp{− 1
σ
ρθ(t,θ)},
where ρθ(t,θ) = t,θ{θ − I(t,θ < 0)} is a loss function, and σ is a scale parameter.
Then the working likelihood can be expressed as
f(data|β, σ) = θ
T (1− θ)T
σT
exp(− 1
σ
RQ(β, θ)), (4.5)
where data denotes (y1, . . . , yT ), and RQ(β, θ) is defined in (4.1).
The appealing property of this working likelihood is that the corresponding maximum likelihood
estimator for β is equivalent to the quantile regression estimator, i.e., the one minimizing RQ(β, θ)
as provided in Engle and Manganelli (2004). An alternative to this parametric working likelihood is
to model the unknown error distribution nonparametrically, such as the Dirichlet process mixture
models developed by Kottas and Krnjajic´ (2009).
4.2.2 Prior and Posterior Specification
We choose a flat prior for each coefficient, βi ∈ Bi, for some interval Bi with i = 1, · · · , p, and
the Inverse Gamma distribution IG(α0, s0) for σ. We assume the impact of the lagged VaR is
bounded, and specify Uniform[−L,L] as the prior distribution for β2, the coefficient associated with
VaRt−1,θ(β), where L is a positive number. Assume independent components, the joint prior for all
parameters is given by
pi(β, σ) ∝ 1
σα0+1
exp(−s0
σ
) for βi ∈ Bi, σ > 0. (4.6)
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The posterior for (β, σ) can be derived as
f(β, σ|data) ∝ f(data|β, σ)pi(β, σ)
=
θT (1− θ)T
σT+α0+1
exp(− 1
σ
RQ(β, θ)− s0
σ
) for βi ∈ Bi, σ > 0.
Yu and Moyeed (2001) proved that the posterior is proper when VaR is a linear function of some
explanatory variables xt, i.e., VaRt,θ(β) = −xTt β(θ). We will prove that the posterior is proper for
CAViaR models, and all posterior moments for β exist under some mild conditions.
Lemma 1 of Yu and Stander (2007)
Let the function g(t) = exp(−|t|), and f(t) = θ(1 − θ) exp(−t[θ − I(t < 0)]), then f(t) has upper
bound g(h1(θ)) and lower bound g(h2(θ)t).
Theorem 4.2.1. If the likelihood is given by ( 4.5) and the prior distribution is given by ( 4.6),
then the corresponding posterior distribution is proper when T ≥ m, where m is the dimension of
improper prior for β. That is,
∫ ∞
0
∫
B
f(β, σ|data)dβdσ <∞, (4.7)
where B = B1 × · · ·Bp, p is the dimension of β, B2 = (−L,L) for some large number L, Bi =
(−∞,∞) for i = 1, 3, · · · , p, p = 3 and m = 2 for the SAV and the indirect GARCH models, p = 4
and m = 3 for the AS model, and p = m = 1 for the Adaptive model. Further, the following posterior
moments of β, ∫ ∞
0
∫
B
|β1|r1 · · · |βp|rpf(β, σ|data)dβdσ, (4.8)
exist if the sample size T > m+ r1 + r3 + · · ·+ rp − α0, where (r1, · · · , rp) denotes the order of the
moments for each element of β.
Proof of Theorem 4.2.1 We consider the SAV model first. For simplicity, let VaRt,θ(β) = Vt.
Expand the SAV model, we have
Vt = β1(1 + β2 + · · ·+ βt−12 ) + βt2V0 + β3(|yt−1|+ β2|yt−2|+ · · ·+ βt−12 |y0|)
= β1(1 + β2 + · · ·+ βt−12 ) + β3(|yt−1|+ β2|yt−2|+ · · ·+ βt−22 |y1|),
where y0 = V0 = 0 WLOG. Note that, the SAV model does not explode if |β2| < L, for some large
L. Therefore, we have B1 = B3 = (−∞,∞), and B2 = (−L,L). According to Lemma 1 of Yu and
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Stander (2007), we have
f(
yt + Vt
σ
) = θ(1− θ) exp[− 1
σ
{θ − I(yt + Vt < 0)}(yt + Vt)]
= g(h(θ)
yt + Vt
σ
)
= exp(−|h(θ)|
σ
|yt + Vt|).
Therefore, the posterior distribution
f(β, σ|data) = 1
σT+α0+1
exp(−s0
σ
− |h(θ)|
σ
T∑
t=1
|yt + Vt|).
It suffices to show that for any r1, r2 r3 ≥ 0, the posterior moment for β
∫ ∞
0
∫
B
p∏
i=1
|βi|rif(β, σ|data)dβdσ
≤
∫ ∞
0
e−s0/σ
σT+α0+1
∫ L
−L
|β2|r2
∫
R2
|β1|r1 |β3|r3 exp(−|h(θ)|
σ
2∑
t=1
|yt + Vt|)dβ1dβ3dβ2dσ (4.9)
is finite. Change variables (β1, β3) to (u, v) with
u = |h(θ)|(y1 + V1)/σ = |h(θ)|(β1 + y1)/σ
v = |h(θ)|(V2 + y2)/σ = |h(θ)|(β1 + β1β2 + β3|y1|+ y2)/σ,
we have
β1 =
σ
|h(θ)|u− y1,
β3 =
−(1 + β2)σ
|h(θ)y1| u+
σ
|h(θ)y1|v +
(1 + β2)y1 − y2
|y1| ,
J =
∣∣∣∣∣∣∣
σ
|h(θ)| 0
−(1+β2)σ
|h(θ)y1|
σ
|h(θ)y1|
∣∣∣∣∣∣∣ =
σ2
h(θ)2|y1| .
Then the integral (4.9) can be re-written as
1
|h(θ)|T+α0 |y1|r3+1
∫ ∞
0
aT+α0−r1−r3−3 exp(− s0|h(θ)|a)
∫ L
−L
|β2|r2
∫
R2
|u− ay1|r1
| − (1 + β2)u+ v + a{(1 + β2)y1 − y2}|r3 exp(−|u| − |v|)dudvdβ2da, (4.10)
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where we change variable σ to a = |h(θ)|/σ. Let I be the integration over (u, v), u = r cos θ, v =
r sin θ, we have
|u− ay1| = |r cos θ − ay1| ≤ r| cos θ|+ a|y1| ≤ r + a|y1|,
| − (1 + β2)u+ v + a{(1 + β2)y1 − y2}|2 ≤ 2(| − (1 + β2)u+ v|2 + |a{(1 + β2)y1 − y2}|2)
≤ 2((1 + β2)2 + 1)(u2 + v2) + a{(1 + β2)y1 − y2}2) (Cauchy-Schwartz Inequality)
= 2((−(1 + β2)2 + 1)r2 + a{(1 + β2)y1 − y2}2),
−|u| − |v| = −r(| cos θ|+ | sin θ|) ≤ −r.
Therefore, we have
I ≤ 2pi
∫ ∞
0
(r + a|y1|)r1 [2{(−(1 + β2) + 1)r2 + a{(1 + β2)y1 − y2}2}]
r3
2 r exp(−r)dr,
which returns polynomial terms of a and β2. Due to the boundedness of β2, integration (4.10) is
finite as long as T > 2+ r1+ r3−α0. Specially T needs to at least m = 2 to have a proper posterior
distribution. 
4.3 Posterior Inference
In this section, we propose a fully Bayesian approach for the estimation and inference on the pa-
rameter β of the CAViaR models.
4.3.1 Element-wise Algorithm
We employ the Gibbs sampler for posterior sampling for the p + 1 dimensional parameters (β, σ).
To implement the Gibbs sampler, we need to derive the conditional distributions for each parameter
given all the other parameters and the data:
f(βi|β[−i], σ,data) ∝ f(data|β, σ)pi(βi), i = 1, · · · , p, and
σ|β,data ∼ IG(T + α0, RQ(β, θ) + s0),
where β[−i] = (β1, · · · , βi−1, βi+1, · · · , βp), and IG stands for the Inverse Gamma distribution with
shape parameter T + α0 and scale parameter RQ(β, θ) + s0.
The posterior distribution for each βi cannot be reduced analytically to a well known distribution,
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so we used a Metropolis within Gibbs sampling to obtain samples of the model parameters from the
posterior distribution.
Details of the element-wise algorithm are as follows.
Initialization: Choose starting values (β0, σ0) as β0i ∼ U(0, 1), i = 1, · · · , p and σ0 ∼ U(0, 1).
Repeat the following sampling steps M times to obtain a chain for the parameters (β, σ):
Step i (i = 1, · · · , p): Sample β˜ti by the Random-Walk Metropolis algorithm (Metropolis et al., 1953)
using the proposal distribution
p(βti |βt1, · · · , βti−1, βt−1i+1 , · · · , βt−1p , σt−1,data) = N(βt−1i , ν2), i = 1, · · · , p,
where ν is a tuning parameter, which will be discussed later. The corresponding Metropolis ratio is
given by
ri =
f(β˜ti |βt1, · · · , βti−1, βt−1i+1 , · · · , βt−1p , σt−1,data)
f(βt−1i |βt1, · · · , βti−1, βt−1i+1 , · · · , βt−1p , σt−1,data)
= exp{− 1
σt−1
(RQ(β˜ti , θ)−RQ(βt−1i , θ))},
where β˜ti = (β
t
1, · · · , βti−1, β˜ti , βt−1i+1 , · · · , βt−1p ), and βt−1i = (βt1, · · · , βti−1, βt−1i , βt−1i+1 , · · · , βt−1p ). Draw
ui ∼ U(0, 1), and set βti to be
βti =
 β˜
t
i , if ui < min{ri, 1},
βt−1i , otherwise.
Step (p+ 1): Sample σ from IG(T + α0, RQ(β, θ) + s0).
4.3.2 Case Study
In the element-wise MCMC implementation, we assume independent flat priors for all the coefficients
on the CAViaR models and update one parameter at a time. To demonstrate a problem with the
MCMC chain, we chose a sample of 3,392 daily prices from April 7, 1986 to April 7, 1999 for
General Motors (GM) as Engle and Manganelli (2004) did. The first 2,892 (T ) daily returns are
treated as the training data or in-sample observations to estimate the model. We chose the starting
values (β0, σ0) as β0i ∼ U(0, 1), i = 1, · · · , p and σ0 ∼ U(0, 1), the tuning parameter, ν, to be 0.05,
and small α0 and s0. It took about 11.2 minutes to obtain a chain of length 60,000 for the four
parameters (three coefficients and one scale parameter) in the 1% SAV model (2.2 GHZ and 2 GB of
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RAM). Summary statistics (mean, median, and standard deviation) are calculated to determine the
burn-in period. According to Figure 4.1, all summary statistics are stable after 50,000. Therefore,
we choose the burn-in period to be 50,000.
We use acceptance rate (AR) to check efficiency of the element-wise algorithm. Gelman et al.
(1996) suggest the cutoff acceptance rate 0.3/d, where d is the dimension of parameters. In the
simulation, AR are 0.1995, 0.0518, and 0.1642 for β1, β2, and β3, respectively for a chain with
length 60,000. Because AR for β2 is too low (less than 0.3/3 = 0.1), the chain is not efficient. We
will use a block algorithm to improve the efficiency in the next section.
4.4 Block Algorithm
It is more efficient to use a block algorithm to sample some coefficients together. This will be referred
to as a preliminary run to sample intercept, β1, and the remaining coefficients, β[−1] = (β2, · · · , βp),
respectively.
4.4.1 Sampling Schemes for Preliminary Run
Details of the preliminary run are as follows.
Initialization: Choose starting values (β0, σ0) as β0i ∼ U(0, 1), i = 1, · · · , p and σ0 ∼ U(0, 1).
Repeat the following sampling steps M times to obtain a chain for the parameters (β, σ):
Step 1: Sample β˜t1 by the Random-Walk Metropolis algorithm with the proposal distribution
p(βt1|βt−1[−1], σt−1,data) = N(βt−11 , ν21),
where ν1 is a tuning parameter, and the target distribution is
f(βt1|βt−1[−1], σt−1,data) ∝
1
(σt−1)T
exp(− 1
σt−1
RQ(β, θ)).
The corresponding Metropolis ratio is given by
r1 =
f(β˜t1|βt−1[−1], σt−1,data)
f(βt−11 |βt−1[−1], σt−1,data)
= exp{− 1
σt−1
(RQ(β˜t, θ)−RQ(βt−1, θ))},
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Figure 4.1: Summary statistics for each parameter in the element-wise MCMC implementation: (a)
mean . (b) median. (c) standard deviation.
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where β˜t = (β˜t1, β
t−1
[−1]), and β
t−1 = (βt−11 , β
t−1
[−1]). Draw u1 ∼ U(0, 1), and set βt1 to be
βt1 =
 β˜
t
1, if u1 < min{r1, 1},
βt−11 , otherwise.
Step 2: Sample β˜t[−1] by the Multivariate Random-Walk Metropolis algorithm with the proposal
distribution
p(βt[−1]|βt1, σt−1,data) = N(βt−1[−1],Σ0),
where Σ0 = ν22R is a variance-covariance matrix, ν2 is a tuning parameter, and R is a correlation
coefficient matrix with diagonal 1. We do not need to implement Step 2 for the Adaptive model
because only β1 exists in that model. The target distribution is
f(βt[−1]|βt1, σt−1,data) ∝
1
(σt−1)T
exp(− 1
σt−1
RQ(β, θ)).
The corresponding Metropolis ratio is given by
r2 =
f(β˜t[−1]|βt1, σt−1,data)
f(βt−1[−1]|βt−11 , σt−1,data)
= exp{− 1
σt−1
(RQ(β˜t, θ)−RQ(βt−1, θ))},
where β˜t = (βt1, β˜
t
[−1]), β
t−1 = (βt1, β
t−1
[−1]). Draw u2 ∼ U(0, 1), and set βt[−1] to be
βt[−1] =
 β˜
t
[−1], if u2 < min{r2, 1},
βt−1[−1], otherwise.
Step 3: Sample σ from IG(T + α0, RQ(β, θ) + s0).
In Step 1, we sample β˜t1 by the Random-Walk Metropolis algorithm. On the other hand, we
can draw β˜t1 from the neighborhood of the mode of the target distribution, i.e., from the proposal
distribution
p(βt1|βt−1[−1], σt−1,data) = N(mode, ν21),
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where the mode can be solved by a maximization problem
max
βt1
f(βt1|βt−1[−1], σt−1,data).
This is equivalent to solve a minimization problem
min
βt1
RQ((βt1, β
t−1
[−1]), θ).
For the SAV model
RQ((βt1, β
t−1
[−1]), θ) =
T∑
t=1
{(zt + βt1)(θ − I(zt + βt1 < 0))},
where zt = yt + βt−12 VaRt−1,θ((β
t−1
1 , β
t−1
[−1])) + β
t−1
3 |yt−1|, the mode is equal to (−1) times the θth
quantile of {zt}Tt=1.
For the AS model
RQ((βt1, β
t−1
[−1]), θ) =
T∑
t=1
{(zt + βt1)(θ − I(zt + βt1 < 0))},
where zt = yt + βt−12 VaRt−1,θ((β
t−1
1 , β
t−1
[−1])) + β
t−1
3 (yt−1)
+βt−14 (yt−1)
−, the mode is equal to (−1)
times the θth quantile of {zt}Tt=1.
For the indirect GARCH model, because RQ((βt1, β
t−1
[−1]), θ) is a nonlinear function of β
t
1, we will
stick with the Random-Walk Metropolis algorithm.
For the Adaptive model,
RQ(βt1, θ) =
T∑
t=1
{(zt + wtβt1)(θ − I(zt + βt1wt < 0))},
where zt = yt +VaRt−1,θ(βt−11 ), and wt = {1 + exp(G{yt−1 +VaRt−1,θ(βt−11 )})}−1 − θ. Therefore,
the mode, βˆ1(θ), is the θth regression quantile of the above RQ function.
4.4.2 Case Study (Continued)
Using the same data analyzed in Subsection 4.3.2, we chose the starting values (β0, σ0) as β0i ∼
U(0, 1), i = 1, · · · , p and σ0 ∼ U(0, 1), the tuning parameter, ν1, and ν2 to be 0.05, and small α0
and s0. Define Rij =cor(βi+1, βj+1) under the posterior. We set R12 to be negative in the SAV
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and indirect GARCH models. Besides, we set R12, R13, and R23 to be negative, negative, and
positive, respectively, in the AS model. These settings are consistent to the estimated correlation
matrix calculated from the independent posterior sequence generated from the element-wise MCMC
implementation (burn-in=50,000 and lag=1,000) on each CAViaR model. In the SAV and indirect
GARCH models, R12 = −0.8037 and −0.8592, respectively. Besides, in the AS model, R12 =
−0.8978, R13 = −0.8015, and R23 = 0.8020. In addition, we set the off-diagonal, Rij , to be 0.5
as the initial guess. The choice of those specific values may not be efficient; therefore, we will
update the variance-covariance structure, Σ0, used in the proposal distribution based on the data
information in the second run.
For the preliminary run, it took about 8.6 minutes to get a chain of length 60,000 for the four
parameters (three coefficients and one scale parameter) in the 1% SAV model (2.2 GHZ and 2 GB of
RAM). The AR values are 0.1885 and 0.0322 for β1 and β[−1], respectively. The AR values decrease
a little bit from 0.0518 and 0.1642 for β2 and β3 in the element-wise MCMC implementation to
0.0322 for β[−1] in the preliminary run using block algorithm. The main reason is the choice of
the variance-covariance matrix, Σ0. Summary statistics (mean, median, and standard deviation)
are calculated to determine the burn-in period. According to Figure 4.2, all summary statistics are
stable after 50,000. Therefore, we choose the burn-in period to be 50,000.
We take lag=1,000 to get nearly independent sequences of β[−1] to update the variance-covariance
matrix used in the proposal distribution for β[−1]. Besides, using the posterior sequences in the
preliminary run, we found that the correlation of the intercept and each slope coefficient is high
(-0.9 for correlation between β1 and β2 and 0.6 for correlation between β1 and β3). This indicates
that the simulation is not efficient because posterior sequences do not move in the high density
area. We suggest to perform reparameterization on the coefficients, i.e., centering each explanatory
variable, to increase the efficiency, and then perform block algorithm on this transformed model.
This will be called a second run. In other words, for the SAV, AS, and indirect GARCH models, we
need to perform the second run on the transformed model using the updated variance-covariance
matrix in the proposal distribution of β[−1] to increase the efficiency of the chain.
In addition, we perform the same sampling schemes except for Step 1, with β˜t1 sampled from the
neighborhood of the mode of the target distribution. It took about 10.1 minutes to get a chain of
length 60,000 for the four parameters (three coefficients and one scale parameter) in the 1% SAV
model. The AR values are 0.1608 and 0.0399 for β1 and β[−1], respectively. Results show that AR
does not increase much over the Random-Walk Metropolis method.
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Figure 4.2: Summary statistics for each parameter in the preliminary run: (a) mean . (b) median.
(c) standard deviation.
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4.4.3 Sampling Schemes for Second Run
Details of the second run are as follows.
Initialization: Do reparameterization on the CAViaR models by centering each explanatory variable,
we get the new intercept β∗1 .
Symmetric Absolute Value (SAV)
β∗1 = β1 + β2VaRt−1, θ(β) + β3|yt−1|, (4.11)
Asymmetric Slope (AS)
β∗1 = β1 + β2VaRt−1, θ(β) + β3(yt−1)+ + β4(yt−1)−, (4.12)
and Indirect GRACH(1, 1)
β∗1 = β1 + β2VaRt−1, θ(β)2 + β3y2t−1, (4.13)
where overline denotes the average over t = 2, · · · , T , and VaRt−1, θ(β) and VaRt−1, θ(β)2 are
calculated using the posterior mean of β on the CAViaR model in the preliminary run.
Repeat the following sampling steps M times to obtain a chain for the parameters (β, σ):
Step 1: Choose starting values (β∗0, σ0) as the posterior mean in the preliminary run, where β∗ =
(β∗1 , β[−1]) .
Step 2: Sample β∗t1 by the Random-Walk Metropolis algorithm as in Step 1 in the preliminary run.
Step 3: Sample βt[−1] by the Multivariate Random-Walk Metropolis algorithm as in Step 2 in the
preliminary run except that the variance-covariance matrix is updated using the variance-covariance
matrix of the posterior sequence of β[−1] from the preliminary run.
Step 4: Sample σ from IG(T,RQ(βt, θ)).
After a burn-in period (B), calculate β1 by (4.11)-(4.13) for SAV, AS, and indirect GARCH models,
respectively, and we obtain the posterior mean for β from the second run.
4.4.4 Case Study (Continued)
We consider two scenarios for the second run, one without reparameterization and one with repa-
rameterization to show that reparameterization improves the efficiency.
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Scenario 1: Without Reparameterization
It took about 7.3 minutes to obtain a chain of length 60,000 for the four parameters, and the
AR values are 0.1983 and 0.1497 for β1 and β[−1], respectively. AR increases from 0.0322 in the
preliminary run to 0.1497 in the second run.
Scenario 2: With Reparameterization
It took about 8.7 minutes to obtain a chain of length 60,000 for the four parameters. AR are 0.1921
and 0.6024 for β1 and β[−1], respectively. AR increases from 0.0322 in the preliminary run to 0.6024
in the second run. Therefore, reparameterization can greatly improves the efficiency of the chain in
the second run.
Summary statistics (mean, median, and standard deviation) are calculated for both scenarios
to determine the burn-in period. According to Figure 4.3, all summary statistics are not stable for
Scenario 1 but are stable after 20,000 iterations for Scenario 2. Therefore, we choose the burn-in
period to be 20,000 for Scenario 2.
To test whether the convergence of the chain depends on the starting values, we perform the
Gelman Rubin diagnostic (GRD) provided in Gelman and Rubin (1992). GRD is based on simulation
of m independent chains with starting values drawn from the same starting distributions, each of
length n after discarding the burn-in period. Denote the ith chain as {xit}t=1,··· ,n, where i =
1, · · · ,m. Between-chain variability, B, and within-chain variability, W , are defined as
B
n
= the variance between the m chain means x¯i·
=
m∑
i=1
(x¯i· − x¯··)2/(m− 1)
W = the average of the m within-chain variances s2i
=
m∑
i=1
s2i /m,
where s2i =
∑n
t=1(xit − x¯i·)2/(n− 1).
The total variability can be estimated by a weighted average of W and B,
σˆ2x =
n− 1
n
W +
1
n
B.
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Figure 4.3: Summary statistics for each parameter in the second run: (a) mean . (b) median. (c)
standard deviation. The left plot refers to without reparameterization, and the right plot refers to
with reparameterization.
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The potential scale reduction is estimated by
Rˆ =
σˆ2x
W
=
n− 1
n
+
1
n
B
W
> 1.
We expect Rˆ to be close to 1 when the chains converge.
After a preliminary run as discussed in Subsection 4.4.2, we obtain a variance-covariance matrix
of β[−1] used in the proposal distribution for β[−1], and a VaR series (VaRt,θ(βˆ), where βˆ is the
posterior mean) used for reparameterization. We generate 10 chains of length 60,000 using the
updated variance-covariance matrix and the starting values, (β∗01 , β
0
2 , β
0
3 , σ
0), drawn from U(0, 1),
respectively. We discard the burn-in period 20,000 for each chain. Therefore, we will have 10
independent chains of length 40,000 in the end. The estimated potential scale reduction, Rˆ, are
1.0003, 1.0002, 1.0004, and 1.000 for β1, β2, β3, and σ, respectively. Because all Rˆ are less than 1.1,
we see no evidence against convergence, and no evidence that the starting values are important.
We conclude that the two stage block algorithm proposed in Subsection 4.4.1 and 4.4.3 is more
efficient compared to the element-wise MCMC implementation provided in Subsection 4.3.1. The
AR values increase from 0.0518 and 0.1642 for β2 and β3, respectively, to 0.6024 for β[−1].
In addition, we perform the same sampling schemes except for Step 1, where β∗t1 is sampled
from the neighborhood of the mode of the target distribution. Without reparameterization, it took
about 9.3 minutes to get a chain of length 60,000 for the four parameters (three coefficients and
one scale parameter) in the 1% SAV model. The AR values are 0.1521 and 0.5505 for β1 and β[−1],
respectively. With reparameterization, it took about 11.0 minutes to get a chain of length 60,000
for the four parameters (three coefficients and one scale parameter) in the 1% SAV model. The AR
values are 0.1607 and 0.1126 for β1 and β[−1], respectively. These results show that AR decreases
over the Random-Walk Metropolis.
4.5 Empirical Investigations on Stable Period
To compare results from the Bayesian approach discussed in the previous section with the estimation
method of Engle and Manganelli (2004), we use the same data analyzed by Engle and Manganelli
(2004). They took a sample of 3,392 daily prices from April 7, 1986 to April 7, 1999 for three
datasets, GM stock price, IBM stock price, and the S&P 500 index. The daily returns are computed
as the difference in the log of successive prices. The first 2,892 (T ) daily returns are treated as the
training data or in-sample observations to estimate the model, and the last 500 (N) daily returns are
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treated as the testing data or out-of-sample observations to access the out-of-sample performance.
4.5.1 Results
According to the sampling schemes provided in Subsections 4.4.1 and 4.4.3, we generate a posterior
sequence, {β1, · · · , βM}, and collet the last J values for the Bayesian inference. Here, J is the length
of the subsequence after excluding the burn-in period. According to the case study in the previous
section, we choose M = 60, 000, J = 40, 000, ν1 = ν2 = 0.05, and small α0 and s0. Besides, we
choose the posterior mean as the parameter estimate for β, and take the 0.025th/0.975th quantiles
of the posterior subsequence as the lower bounds/upper bounds (LBs/UBs) of the credible intervals
for β. For each vector in the posterior subsequence, βj , we calculate VaR series (VaRt,θ(βj), t =
1, · · · , T+N) according to any of the four CAViaR models. For each VaR series, we further calculate
the Hits series (Hitst(βj)) and the RQ value (RQ(βj , θ)). Hits in-sample sequence (HitsIS(βj)) is
the average of the first T Hits series, and Hits out-of-sample sequence (HitsOOS(βj)) is the average
of the last N Hits series, i.e., HitsIS(βj) =
∑T
1 Hitst(β
j)/T , HitsOOS(βj) =
∑T+N
T+1 Hitst(β
j)/N,
and Hitst(βj) is defined as I(yt < −VaRt,θ(βj)) − θ. We use the posterior means of the Hits in-
sample sequence and the Hits out-of-sample sequence as the estimates for Hits in-sample and Hits
out-of-sample, and calculate the corresponding credible intervals and Monte Carlo standard errors
(MCSEs) for the posterior mean. In addition, we use the posterior mean of RQ as the estimate
for the RQ measure, and calculate the corresponding credible interval and MCSE for the posterior
mean. The detail for calculating MCSE is based on Flegal et al. (2008). Suppose we have a posterior
sequence bj , j = 1, · · · , J for b, we use posterior mean b¯ =∑J1 bj/J to estimate b. According to the
CLT,
√
J(b¯− E(b|data))→ N(0, σ2b ) in distribution as J →∞
We break the sequence into blocks of equal size, and calculate batch means estimate of b. Suppose
that cJ is the batch size, aJ is the number of batches, aJcJ = J , and b¯k is the batch mean for each
block, i.e.,
b¯k =
1
cJ
kcJ∑
j=(k−1)cJ+1
bj , k = 1, · · · , aJ .
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The batche means estimate of σ2b is
σˆ2b =
cJ
aJ − 1
aJ∑
k=1
(b¯k − b¯)2.
Finally, the MCSE for b¯ is σˆb/
√
J . Flegal et al. (2008) suggests that cJ = [
√
J ], and aJ = [J/cJ ] is
a convenient choice that works well in applications. Therefore, we use MCSE to access the accuracy
of the point estimate, b¯. We have several interesting findings based on Table 4.1 to Table 4.3.
Compared to the confidence intervals constructed by Engle and Manganelli (2004), we find that the
length of the intervals from our Bayesian approach is much shorter. Besides, credible intervals and
confidence intervals for β are overlapping except for the intercept β1 in the SAV model on the S&P
500 index. When we use Engle and Manganelli’s approach, we will obtain a higher estimate for β1
in this case. In addition, Engle and Manganelli’s method of estimation did not find the optimal
quantile estimates that minimize the objective function, RQ, because smaller RQ was attained in
the SAV model for the S&P 500 data by the Bayesian approach. The smallest RQ appeared in
the AS model for both approaches. Therefore, the AS model has the largest Pseudo-R2 according
to equation (4.2). Importantly, the performance of CAViaR models is better using the Bayesian
approach than Engle and Manganelli’s approach based on Hits in-sample and Hits out-of-sample
criteria. The posterior estimates for Hits in-sample and Hits out-of-sample are very close to the
theoretical value, 0, but not for Engle and Manganelli’s approach. The smallest Hits out-of-sample
measure tends to appear in the Adaptive model. The posterior distributions of Hits in-sample and
Hits out-of-sample are provided in Figure 4.4-Figure 4.7. In the Hits in-sample plots, Hits are
centered around the theoretical value, 0, for the SAV, AS, and indirect GRACH models, but not so
for the Adaptive model. Therefore, the Adaptive model does not fit the data well. In the Hits out-
of-sample plots, although the Hits are not centered around 0, the mean is closer to zero than Engle
and Manganelli’s method. Take 1% GM Hits out-of-sample using the SAV model for example, the
range is [0, 0.004] for the Bayesian approach, as compared to 0.4 for Engle and Manganelli’s method.
Besides, we plot the estimated 1% VaRs for the first 10 days in the out-of-sample period with credible
intervals for GM. Figure 4.8 shows similar patterns but different scales of the estimated VaR from
the Bayesian approach and Engle and Manganelli’s approach. The estimated VaRs are larger from
the Bayesian approach compared to Engle and Manganelli’s approach except for the Adaptive model
for these 10 days. We found that the fluctuation from the Adaptive model is very mild due to the
unit coefficient on the lagged VaR. Returns in the third and fourth days are 1.4907 and -3.4512,
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respectively. Therefore, we have the highest VaR in the fifth day from all models.
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Figure 4.4: Relative Frequency of 1% Hits in-sample for each of the three datasets. Hits in-sample
are centered around the theoretical value, 0, compared to the Engle and Manganelli’s point estimates
that are not in the scale of the box.
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Figure 4.5: Relative Frequency of 1% Hits out-of-sample for each of the three datasets. Although
almost all Hits out-of-sample are not centered around 0, the means are closer to zero compared to
Engle and Manganelli’s point estimates that are not in the scale of the box.
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Figure 4.6: Relative Frequency of 5% Hits in-sample for each of the three datasets. Hits in-sample
are centered around the theoretical value, 0, compared to the Engle and Manganelli’s point estimates
that are not in the scale of the box.
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Figure 4.7: Relative Frequency of 5% Hits out-of-sample for each of the three datasets. Although
almost all Hits out-of-sample are not centered around 0, the means are closer to zero compared to
Engle and Manganelli’s point estimates that are not in the scale of the box.
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Figure 4.8: Returns and 1% estimated VaR plots for GM for the first 10 days in the out-of-sample
period. The left plot with 95 % pointwise credible bands is based on the Bayesian approach, and
the right plot is based on Engle and Manganelli’s approach.
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4.6 Empirical Investigations on Global Financial Crisis
In this section, we investigate the performance of our method in a volatile period. We use a sample
of 3,525 daily indices from January 2, 1996 to January 2, 2010 for the S&P 500 index. Daily returns
are computed as arithmetic return (the ratio of the difference between two successive indices to the
first index). Figure 4.9 shows the indices and returns over this period including global financial
crisis. We choose September 15, 2008 as the cutoff to split the data into two sets, training period
and testing period. The first 3,197 (T ) daily returns are treated as the training data or in-sample
observations to estimate the model, and the last 328 (N) daily returns are treated as the testing
data or out-of-sample observations to assess the out-of-sample performance.
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Figure 4.9: S&P 500 index from January 2, 1996 to January 2, 2010. September 15, 2008 is chosen
as the cutoff to split the data into training period and testing period.
4.6.1 Results
We choose M = 60, 000, J = 40, 000, ν1 = ν2 = 0.005 for the MCMC algorithm described in
Section 4.4. We have several interesting findings based on Table 4.4. Compared to the confidence
intervals from Engle and Manganelli’s approach, we find that the length of the intervals from the
Bayesian approach is much shorter. Besides, credible intervals and confidence intervals for β are
overlapping. In addition, Engle and Manganelli’s method of estimation did not find the optimal
quantile estimates that minimize the objective function, RQ, because smaller RQ was attained on
each CAViaR model by the Bayesian approach. The smallest RQ appeared in the AS model for both
approaches. Therefore, the AS model has the largest Pseudo-R2. Importantly, the performance of
CAViaR models is better using the Bayesian approach than Engle and Manganelli’s approach based
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on Hits in-sample and Hits out-of-sample criteria. The posterior estimates for Hits in-sample and
Hits out-of-sample are very close to the theoretical value, 0, but not for Engle and Manganelli’s
approach. The smallest Hits out-of-sample measure tends to appear in the Adaptive model. The
posterior distributions of Hits in-sample and Hits out-of-sample are provided in Figure 4.10. In
the Hits in-sample plots, Hits are centered around the theoretical value, 0, for the SAV, AS, and
indirect GRACH models, but not so for the Adaptive model. Therefore, the Adaptive model does
not fit the data well. In the Hits out-of-sample plots, although the Hits are not centered around 0,
the mean is closer to zero than Engle and Manganelli’s method. Take 1% Hits out-of-sample using
the SAV model for example, the range is [0.017, 0.034] for the Bayesian approach, as compared
to 1.134 for Engle and Manganelli’s method. Besides, we plot estimated 1% VaRs for the 30 days
before and after cutoff (September 15, 2008) with credible intervals and confidence intervals for both
approaches. Take the indirect GARCH as an example, we describe how to obtain the confidence
interval for VaRt,θ(β). According to Theorems 2 and 3 of Engle and Manganelli (2004), we have
√
TA
−1/2
T DT (βˆ − β) D→ N(0, I),
where
AT ≡ E
[
T−1θ(1− θ)
T∑
t=1
∇′VaRt,θ(β)∇VaRt,θ(β)
]
,
DT ≡ E
[
T−1
T∑
t=1
ft∇′VaRt,θ(β)∇VaRt,θ(β)
]
,
ft is the conditional density function of t,θ evaluated at 0, and ∇VaRt,θ(β) is the gradient of
VaRt,θ(β). Therefore,
V ar(βˆ) = T−1D−1T ATD
−1
T .
Under some regularity conditions, the consistent estimators for AT and DT are
AˆT = T−1θ(1− θ)
T∑
t=1
∇′VaRt,θ(βˆ)∇VaRt,θ(βˆ),
DˆT = (2T cˆT )−1
T∑
t=1
I(|yt +VaRt,θ(βˆ)| < cˆT )∇′VaRt,θ(βˆ)∇VaRt,θ(βˆ),
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where cˆT is a bandwidth satisfies cT = o(1), c−1T = o(T
1/2), and cˆT /cT → 0 in probability. The
indirect GRACH model can be written as
VaR2t,θ(β) = B3β,
where B3 = (1, VaRt−1,θ(β)2, y2t−1), and β = (β1, β2, β3)
T . We have
V ar( ˆVaR
2
t,θ(βˆ)) = Bˆ3V ar(βˆ)Bˆ
T
3 ,
where Bˆ3 = (1, ˆVaRt−1,θ(βˆ), y2t−1). According to the Delta method, we have
V ar( ˆVaRt,θ(βˆ)) =
1
4 ˆVaR
2
t,θ(βˆ)
Bˆ3V ar(βˆ)BˆT3 .
Therefore, (1− θ) confidence interval for VaRt,θ(β) is
ˆVaRt,θ(βˆ)± Zθ/2
√
V ar( ˆVaRt,θ(βˆ)),
where Zθ/2 denotes the (1 − θ/2)-th quantile of the standard normal distribution. Similarly, we
can obtain confidence intervals for other CAViaR models. Figure 4.11 shows similar patterns of the
estimated VaR, but different widths of CI from the Bayesian approach and Engle and Manganelli’s
approach. We found that the fluctuation of VaR from the Adaptive model is very mild due to the unit
coefficient on the lagged VaR. Before the cutoff, we have small VaRs because of the stable returns.
However, we have large VaRs after the cutoff because of the volatile returns. The confidence intervals
from Engle and Manganelli’s approach are much wider than the Bayesian approach, especially for
the indirect GARCH model.
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Figure 4.10: Relative Frequency of Hits in-sample and Hits out-of-sample for S&P 500. Hits in-
sample are centered around the theoretical value, 0, compared to the Engle and Manganelli’s point
estimates that are not in the scale of the box except for 1% Hits in-sample using SAV model.
Although almost all Hits out-of-sample are not centered around 0, the means are closer to zero
compared to Engle and Manganelli’s point estimates that are not in the scale of the box.
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Figure 4.11: Returns and 1% estimated VaR plots for S&P 500 index for the 30 days before and after
the cutoff. The left plot with 95 % pointwise credible bands is based the Bayesian approach, and
the right plot with 95% pointwise confidence bands is based on Engle and Manganelli’s approach.
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